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The removal of noncoding sequences, or introns, from the eukaryotic messenger RNA 
precursors is catalyzed by a ribonucleoprotein complex known as the spliceosome. In most 
eukaryotes, two distinct classes of introns exist, each removed by a specific type of 
spliceosome. The major, U2-type introns account for over 99 % of all introns, and are almost 
ubiquitous. The minor, U12-type introns are found in most but not all eukaryotes, and reside 
in conserved locations in a specific set of genes. Due to their slow excision rates, the U12-type 
introns are expected to be involved in the regulation of the genes containing them by 
inhibiting the maturation of the messenger RNAs. However, little information is currently 
available on how the activity of the U12-dependent spliceosome itself is regulated. 
The levels of many known splicing factors are regulated through unproductive alternative 
splicing events, which lead to inclusion of premature STOP codons, targeting the transcripts 
for destruction by the nonsense-mediated decay pathway. These alternative splice sites are 
typically found in highly conserved sequence elements, which also contain binding sites for 
factors regulating the activation of the splice sites. Often, the activation is achieved by binding 
of products of the gene in question, resulting in negative feedback loops. 
In this study, I show that U11-48K, a protein factor specific to the minor spliceosome, 
specifically recognizes the U12-type 5' splice site sequence, and is essential for proper 
function of the minor spliceosome. Furthermore, the expression of U11-48K is regulated 
through a feedback mechanism, which functions through conserved sequence elements that 
activate alternative splicing and nonsense-mediated decay. This mechanism is conserved from 
plants to animals, highlighting both the importance and early origin of this mechanism in 
regulating splicing factors. I also show that the feedback regulation of U11-48K is 
counteracted by a component of the major spliceosome, the U1 small nuclear 
ribonucleoprotein particle, as well as members of the hnRNP F/H protein family. These results 
thus suggest that the feedback mechanism is finely tuned by multiple factors to achieve 
precise control of the activity of the U12-dependent spliceosome.  
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1 Review of the literature 
1.1 Introduction 
Splicing of messenger RNA precursors (pre-mRNAs) is a ubiquitous eukaryotic process that 
affects virtually all protein-coding transcripts in humans, and thus has wide implications for 
normal gene expression, as well as for disease (reviewed by Wang and Cooper, 2007). 
However, the discovery that eukaryotic genes are discontinuous (Berget et al., 1977; Chow et 
al., 1977) was initially met with amazement and even incredulity. Understandably, the reason 
for maintaining such apparently useless DNA was initially difficult to fathom. Even more 
puzzling was the question of how the intervening regions, or introns, as they became known, 
were properly recognized and removed from the expressed regions, or exons. There seemed to 
be very little information in the introns themselves, and no pattern similar to the well-known 
protein-encoding genetic code was to be found. Yet, the precise removal of introns was crucial 
to maintaining the correct reading frame in the resulting messenger-RNA (mRNA), and thus 
for the expression of the correct proteins. The observation that some of the small nuclear 
RNAs (snRNAs) bore sequences compatible to the splice site sequences (Lerner et al., 1980; 
Rogers and Wall, 1980), paved way for the realization that the splicing machinery, the 
spliceosome, is itself a ribonucleoprotein (RNP) complex. While highly degenerate, the splice 
sites are nonetheless recognized by snRNA-containing small nuclear RNPs (snRNPs) through 
base-pairing interactions with the snRNAs (Mount et al., 1983; Black et al., 1985).  
The situation became even more complex with the discovery of alternative splicing. This 
process was originally found in immunoglobulin transcripts, the alternative isoforms of which 
produce the membrane-bound and soluble antibodies (Alt et al., 1980; Early et al., 1980; 
Rogers et al., 1980). While this observation offered an insight into how splicing could be 
useful, i.e. by producing mRNAs for alternative protein isoforms from one gene (reviewed by 
Breitbart et al., 1987), it underscored the inherent puzzle in splicing: How are the proper 
splice sites selected? It became clear that the splice site sequences themselves were not the 
only determinants of splicing, as the recognition of splice site sequences was found to be 
affected by exonic sequences (Somasekhar and Mertz, 1985; Reed and Maniatis, 1986). Over 
time, it was recognized that splicing regulatory elements play a crucial role in splice site 
activation in both constitutive and alternative splicing. Alternative splicing was also found to 
be a more common event than originally expected, particularly after completion of the human 
genome sequencing project (Lander et al., 2001), when it became obvious that the complexity 
of the human proteome heavily depends on alternative splicing to produce the protein isoforms 
that are many-fold more numerous than the genes encoding them (reviewed by Nilsen and 
Graveley, 2010).  
Almost as surprising as the discovery of splicing itself was the discovery of a rare class of 
introns (Jackson, 1991; Hall and Padgett, 1994) that were found to be excised by a separate 
spliceosome with its own set of snRNPs analogous to, but distinct from those of the canonical 
major spliceosome (reviewed by Patel and Steitz, 2003). Why should this be? What possible 
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use could an organism have for two machineries performing essentially identical tasks? The 
low frequency, inefficient excision and extremely conserved splice site sequences of these 
minor, or U12-type introns, as well as their absence from many organisms, initially suggested 
that they may be molecular fossils, slowly being purged from the genomes of eukaryotes. 
However, their retention in homologous locations over hundreds of millions of years of 
evolution suggests that they have important functions. The importance of U12-dependent 
splicing is likely linked to its regulatory role in controlling the expression of the specific set of 
genes containing U12-type introns and, ultimately, the downstream effects of those genes. The 
emerging view is that the various splicing processes are linked to each other as well as other 
steps of the gene expression pathway, with cross-regulation apparent at every level. 
1.2 Overview of eukaryotic pre-mRNA processing 
The initial step in the expression of proteins in all cellular organisms is transcription, during 
which the nucleotide sequence of DNA is copied into a complementary sequence in RNA. In 
eukaryotes, chromosomes are tightly packed within the nucleus of the cell, and 
transcriptionally active and inactive parts of the chromosomes are sequestered in different 
domains of the nucleus (reviewed by Lanctôt et al., 2007). To become accessible to RNA 
polymerase, the DNA must be unpacked from the chromatin complexes. A number of 
enzymes regulate the affinity of histones for DNA within the chromatin by modifying a 
specific set of histone amino acid residues. Once the DNA has become accessible, a set of 
transcription initiation factors is assembled within the promoter region of a gene, and they in 
turn recruit the RNA polymerase (reviewed by Valen and Sandelin, 2011). This process is 
regulated by enhancer and silencer elements, which can be located thousands of nucleotides 
away from the promoter, and exert their effect by binding regulatory factors which either 
promote or suppress transcription initiation. As transcription proceeds, the nascent transcript is 
processed in various ways, including capping at its 5' end, splicing to remove the non-coding 
intronic sequences and finally polyadenylation at its 3' end (see the following chapter). All of 
these steps are generally required before the mature mRNA is transported into the cytoplasm 
(see chapter 1.7.2), where it can function as a template for protein synthesis. Among these 
steps, splicing has emerged as a highly versatile process, which not only removes introns with 
high fidelity, but can also give rise to alternative mRNA isoforms, and thus proteins, as well as 
regulate gene expression by producing non-viable mRNA variants. 
1.2.1 Co-transcriptional nature of pre-mRNA processing 
In eukaryotes, pre-mRNAs are transcribed by RNA polymerase II (RNAPII). Together with 
the chromatin template, the growing transcript and other associated factors, the polymerase 
forms a transcription elongation complex (TEC; reviewed by Perales and Bentley, 2009). The 
TEC is a multifunctional assembly, which co-ordinates a large number of interdependent RNA 
as well as chromatin processing events (reviewed by Phatnani and Greenleaf, 2006). One of 
the central elements in this complex is the C-terminal domain (CTD) of the large subunit of 
RNAPII, composed of a large number (52 in mammals) of YSPTSPS heptapeptide repeats. 
The phosphorylation state of these repeats controls the initiation and elongation phases of 
transcription, and also co-ordinates the assembly of pre-mRNA processing factors (reviewed 
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by Phatnani and Greenleaf, 2006). For example, as the transcript is initiated, the CTD is 
phosphorylated on the Ser5 residues of its heptapeptide repeats, allowing the loading and 
activation of the capping enzyme (Ho and Shuman, 1999). Towards the end of the transcript 
the CTD becomes phosphorylated predominantly at Ser2, and recruits  and activates 3' end-
processing factors (reviewed by Perales and Bentley, 2009). The interactions are also 
reciprocal, with pre-mRNA processing factors activating or inhibiting transcription elongation 
(Perales and Bentley, 2009). 
Whether splicing factors associate physically with RNAPII is not equally well established, 
although a number of interactions between them have been observed. Splicing factors are 
found in complexes with RNAPII (Das et al., 2007; Sapra et al., 2009), and can also activate 
recruitment of transcription factors to the promoter and enhance elongation (Damgaard et al., 
2008; Lin et al., 2008). On the other hand, splicing factors appear to be recruited only to 
intron-containing, but not intronless transcripts, suggesting that RNAPII does not directly 
promote their binding or at least is not the only factor doing so (Listerman et al., 2006; Moore 
et al., 2006). Despite the lack of information on the physical relationship between splicing 
factors and RNAPII, the co-transcriptional nature of splicing is well documented. Looped 
RNAs attached to chromatin have been observed by electron microscopy (Beyer and Osheim, 
1991), spliced mRNAs are associated with isolated chromatin (Bauren and Wieslander, 1994; 
Pandya-Jones and Black, 2009) and spliced mRNAs can be detected on their chromosomal 
gene loci by RNA in situ hybridization (Zhang et al., 1994). Also, synthetic pre-mRNAs are 
spliced less efficiently than co-transcriptionally spliced transcripts both in vitro and in vivo, 
and CTD phosphorylation is required for efficient co-transcriptional splicing (Bird et al., 
2004; Das et al., 2006). Finally, with long genes, the removal of most introns is completed 
before the pre-mRNA is fully transcribed (Singh and Padgett, 2009), verifying that splicing 
takes place co-transcriptionally. Splicing is also linked to other steps of pre-mRNA 
processing, including capping (Görnemann et al., 2005) and export, as well as quality control 
mechanisms in the nucleus, such that only correctly and rapidly processed mRNAs are 
packages into mature messenger RNPs (mRNPs) that are exported into the cytoplasm for 
translation (see chapter 1.7). 
1.2.2 Variation and origins of spliceosomal introns 
1.2.2.1 Prevalence of introns 
Introns are one of the features typical of eukaryotic genomes, but different eukaryotes vary 
widely with respect to the length and density of their introns. Some unicellular eukaryotes 
contain only a few introns in total in their genomes (Nixon et al., 2002; Vanacova et al., 
2005), and at least one cryptophyte has lost its introns altogether (Lane et al., 2007). In 
contrast, multicellular eukaryotes with larger genomes typically have a larger number of 
introns, which are also longer and in some cases constitute a much larger fragment of their 
genomes than the protein-coding exonic sequences (Deutsch and Long, 1999). In humans, the 
lengths of the introns vary from less than 100 basepairs (bp) to several hundred kilobases (kb), 
with the mean length of 3300 bp (Lander et al., 2001) and the average number of introns per 
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gene (intron density) of 6.9 (Csuros et al., 2011). The most extreme case of intron density and 
coverage in the human genome is the gene which codes for the muscle-specific protein 
dystrophin. The total length of the gene is 2.5 million bp, and it contains 79 exons, which 
constitute only 1% of the total length of the gene (Pozzoli et al., 2002). On the other hand, in 
baker's yeast Saccharomyces cerevisae, a commonly used model organism in biology, only a 
subset of genes harbor introns, and typically no more than one intron per gene, with an 
average intron density of 0.1 (Csuros et al., 2011). Introns in the yeast genome are also 
considerably shorter than in mammals, with lengths varying between 50–1000 bp. 
1.2.2.2 Introns and evolution 
Such a wide range of varying intron sizes and densities suggest that the importance of introns 
and splicing has varied in different evolutionary lineages. How, then, did this variation arise 
during evolution? A number of theories accounting for the origins of introns have been 
proposed, and they can be roughly divided into two models known as "introns-late" and 
"introns-early" (Darnell, 1978; Doolittle, 1978). According to the introns-late model, introns 
were introduced (possibly through horizontal gene transfer) to a eukaryotic ancestral protein-
coding DNA genome, or independently into several eukaryotic lineages. The introns-early 
model postulates that introns arose before or together with protein coding sequences or else 
were inserted into protein-coding RNA genomes before DNA was adopted as the hereditary 
material. In a more stringent version of the introns-early model, known as the "introns-first" 
model (Jeffares et al., 1998; Penny et al., 2009), introns are seen as remnants of the original 
RNA world (Gilbert, 1986), representing genes for ribozymes and other functional RNAs, 
which later became interspersed with spacers that evolved into protein coding sequences of 
today. Both the introns-early and introns-first models necessitate that spliceosomal introns 
were already extant before the last eukaryotic common ancestor (LECA), and may also have 
been present in the ancestors of modern archaea and/or bacteria. 
Yeast is one of the most common model organisms used in splicing studies. As mentioned, the 
yeast genome is very intron-poor. Yeast introns typically have very precisely defined splice 
site sequences and are not alternatively spliced. Such a minimal, stringent splicing system has 
traditionally been considered to be the original primitive mode of splicing in LECA, thus 
lending support for the introns-late theory (Logsdon, 1998).  However, recent comparisons 
across eukaryotes have clearly shown that the common eukaryotic ancestor instead had introns 
and spliceosomes very similar to most modern eukaryotes, i.e. high intron density, weakly 
conserved splice sites, both U2 and U12-type introns and complex spliceosomes (reviewed by 
Koonin, 2009; Roy and Irimia, 2009). It appears that intron loss is a common phenomenon in 
many eukaryotic lineages, while massive expansion in intron numbers has only taken place a 
few times during evolution, most notably in the common ancestor of Metazoa (Csuros et al., 
2011). In very intron-sparse lineages, such as yeast, intron loss is correlated with reduction in 
the genome size and with the emergence of highly regular splice sites, suggesting that all these 
characteristics are a product of high selection pressure on these fast-reproducing organisms 
(reviewed by Koonin, 2009; Penny et al., 2009). Thus, introns appear to have arisen well 
before the LECA, but whether their origins are in the RNP or RNA world remains unresolved. 
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1.2.2.3 Relationship of spliceosomal introns to self-splicing introns 
In addition to spliceosomal introns, many types of organisms carry self-splicing introns, which 
are divided into group I and group II introns based on their different catalytic mechanisms 
(reviewed by Bonen and Vogel, 2001; Haugen et al., 2005; Fedorova and Zingler, 2007). They 
are rarely found in archaea, but are common in bacteria and in eukaryotic mitochondria and 
chloroplasts, and are also present in some nuclear genes encoding ribosomal RNAs. Self-
splicing introns of the same type show a high degree of structural conservation, which is 
required for their autocatalytic excision. They also often carry open reading frames encoding 
proteins that enhance the splicing activity and also enable the insertion of the excised intron 
into DNA, allowing the introns to function as retrotransposons. Excision of group II introns 
and spliceosomal introns proceeds through a similar catalytic mechanism, which has prompted 
the hypothesis that group II introns may be evolutionarily related to both the spliceosome and 
spliceosomal introns (Hickey, 1992; Stoltzfus, 1999). A number of functional similarities 
support this hypothesis: Both intron types are excised through a similar two-step 
transesterification reaction, and the structures of spliceosomal snRNAs are similar to the 
catalytically active domains of group II introns and they even have interchangeable activities 
in certain cases (reviewed by Valadkhan, 2010). Furthermore, constructs based on 
spliceosomal snRNAs can perform splicing reactions in vitro in the absence of proteins, 
similar to group II introns (Valadkhan et al., 2009). However, there currently is no clear 
evidence to show whether the spliceosome is derived from group II introns or shares a 
common ancestor with it, and it has been noted that group II introns and spliceosomal introns 
may merely have gained similar characteristic through parallel evolution due to performing 
similar chemical functions (Weiner, 1993).  
1.3 Minor and major introns 
1.3.1 Intron structure 
The excision of self-splicing introns relies on specific structures within the introns themselves, 
and the introns are therefore highly conserved sequence elements. In contrast, spliceosomal 
introns are removed by a trans-acting spliceosome, and have therefore diverged significantly, 
with little sequence conservation between different introns. However, they do contain three 
regions of moderate conservation. The scissile phosphodiester bond at the 5' splice site (5'ss) 
is located in a conserved element, known as the 5'ss sequence, which generally includes the 
first six nucleotides of the intron, as well as up to three nucleotides in the exon (Figure 1). 
Similarly, the 3' splice site (3'ss) is preceded by a conserved intronic region. Finally, the 
catalytically active branch point (BP) adenosine resides within the branch point sequence 
(BPS) located at a variable distance upstream of the 3'ss. These are the sequences that are 
recognized by the core spliceosomal components during spliceosome assembly and are also 
involved in the catalytic steps required for intron removal and exon ligation.  




Figure 1. Intron structure and consensus sequences. 
A) Schematic depiction of (U2-type) intron structure in the coding strand of a typical eukaryotic gene. Exons 
are depicted as boxes, and the intron as a line, with key sequence elements highlighted by letters. The 
locations of the scissile phosphodiester bonds at the splice sites (5'ss and 3'ss) are indicated by arrows, as 
well as the location of the branch point (BP) adenosine. The approximate locations of the conserved 
sequence elements are indicated below the intron, including the 5'ss sequence, the branch point sequence 
(BPS), and the polypyrimide tract (PPT) together with the 3'ss sequence. 
B) Human U2 and U12-type intron consensus sequences The consensus sequences of the 5'ss, BPS, and 
3'ss (with PPT included) of U2 and U12-type introns are depicted schematically, with the height of the 
letters proportional to the frequency of the corresponding base at that position. The 5'ss, BP and 3'ss are 
indicated by arrows. Adapted with modifications from Roy and Irimia (2009), with permission from Elsevier. 
1.3.2 Characteristics of U2-type and U12-type introns 
There are two parallel sets of spliceosomal introns in eukaryotes, the U2-type introns and 
U12-type introns (reviewed by Patel and Steitz, 2003). U2-type introns account for the 
majority of introns in any given eukaryote (over 99%), while U12-type introns are only found 
in a handful of genes, and the intron types are thus also known as the major and minor introns, 
respectively. The length of both intron types varies greatly, and they have similar average 
length (Levine and Durbin, 2001). However, there is a large subset of small U2-type introns of 
less than 100 bp, while such short U12-type introns are relatively rare (Levine and Durbin, 
2001). This has led to the assumption that intron recognition may differ for the two intron 
types, with U12-type splicing relying more strictly on the so called exon definition 
interactions (see chapter 1.6.1). 
The organization of both types of introns is similar, but they differ significantly in the precise 
sequence composition of their splice sites and BPS, such that they can be easily differentiated 
from one another based on these sequences (Figure 1B). The overall consensus for the U2-
type 5'ss sequence is AG/GTAAGT, with the slash denoting the 5'ss (Sheth et al., 2006). The 
level of sequence conservation varies greatly between different organisms, and organisms with 
low intron density typically also have very conserved 5'ss sequences (chapter 1.2.2.2). For 
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example, 84 % of the introns in Cryptosporidium parvum contain the precise consensus 
sequence, while in human introns the corresponding figure is only 14 % (Irimia et al., 2007). 
The U2-type 3'ss is marked by a much shorter signal, CAG, at the very end of the intron. The 
U2-type BPS is generally located 20–40 bp upstream of the 3'ss, and shows considerable 
sequence variation, similar to the 5'ss sequence (Gao et al., 2008; Corvelo et al., 2010). 
Between the BPS and the 3'ss lies the polypyrimidine tract (PPT), the length of which varies 
significantly and is generally indicative of the strength of the 3'ss, and can also compensate for 
weak BPSs (Corvelo et al., 2010).  
In contrast to the U2-type splicing signals, the U12-type introns show a much higher degree of 
conservation in theirs. The U12-type 5'ss sequence almost invariably conforms to the 
consensus /RTATCCTTT (in which R is a purine) in all organisms, although occasional 
deviations occur (Figure 1B; Sheth et al., 2006; Lin et al., 2010). The BPS is similarly highly 
conserved, and is much more pyrimidine rich than that of U2-type introns. Conversely, no 
conserved PPT has been observed in U12-type introns. The 3'ss is marked only by the terminal 
nucleotides, which typically are YAG (where Y is a pyrimidine) in introns starting with GT, 
and YAC in introns with AT at the 5'ss, although many different dinucleotide combinations 
can be recognized as a 3'ss (Dietrich et al., 2001; Levine and Durbin, 2001; Hastings et al., 
2005). However, the distance of a U12-type BPS from the 3'ss is typically much more 
restricted (10–20 bp) than for U2-introns, and it has been shown that the distance is a crucial 
factor for recognition of the 3'ss (Dietrich et al., 2001; Levine and Durbin, 2001; Zhu and 
Brendel, 2003; Dietrich et al., 2005). 
1.3.3 Conversion of intron types, and evolution of U12-type introns 
The existence of U12-type introns and/or U12-dependent splicing factors in almost all of the 
major eukaryotic lineages suggests that U12-type introns are of ancient origin, similarly to 
U2-type introns (Russell et al., 2006; Bartschat and Samuelsson, 2010). However, they are 
entirely absent from many eukaryotes whose relatives nonetheless have them, suggesting 
repeated loss of U12-dependent splicing during evolution. The loss seems to have been most 
prevalent among diverse eukaryotic microbes, such as algae, unicellular fungi and amoebozoa, 
but some animals, including some but not all nematodes, have also lost their U12-type introns 
(Russell et al., 2006; Bartschat and Samuelsson, 2010). Interestingly, the genome of the 
nematode Caenorhabditis elegans still contains vestigial U12-type introns that are now spliced 
by the U2-dependent spliceosome (Sheth et al., 2006), supporting the idea that its U12-type 
introns have been converted to U2-type relatively recently.  
As discussed in chapter 1.2.2.2, the loss of U12-type introns probably reflects the high 
selection pressures affecting intron density in general during the evolution of these organisms. 
How, then, do U12-type introns become lost? As the vestigial U12-type introns of C. elegans 
suggest, one likely pathway is the step-wise conversion of U12-type introns into U2-type 
introns. Natural examples as well as experimental approaches have also shown that simple 
point mutations in the 5'ss of a U12-type intron, especially in the GT-AG subtype, suffice to 
turn it into a U2-type 5'ss (Dietrich et al., 1997; Burge et al., 1998; Lin et al., 2010), as U2-
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type introns have much more degenerate splicing signals (Figure 1B). Furthermore, changes in 
the terminal dinucleotides of U12-type introns occur readily in nature (Sheth et al., 2006; Lin 
et al., 2010), thus enabling other U12-subtypes to become GT-AG introns. Sometimes the 
conversion can also occur by activation of a cryptic U2-type 5'ss near the original U12-type 
5'ss (Bartschat and Samuelsson, 2010). It has been also noted that the pyrimidine-rich BPS of 
U12-type introns could efficiently function as a PPT for the newly created U2-type intron 
(Burge et al., 1998). Given that the chance of creating the highly stringent U12-type 5'ss from 
a U2-type 5'ss is low, conversion in the reverse direction is a highly unlikely event. In fact, 
only one instance of a novel U12-type intron has been observed (Lin et al., 2010). Thus, 
without natural selection acting in favour of maintaining U12-type introns, they are likely to 
be converted into U2-type introns during evolution. 
Such a unidirectional conversion from U12-type introns to U2-type has raised the hypothesis 
that U12-type introns would have been much more prevalent during the early history of life, 
and that they might in fact be ancestral to U2-type introns. A further indication of this could 
be the fact that U12-type introns appear to resemble group II introns more closely (for 
discussion, see Roy and Irimia, 2009), assuming that spliceosomal introns are indeed derived 
from group II introns (see chapter 1.2.2.3). However, an analysis of amino acid distributions at 
intron insertion sites retained between human and Arabidopsis thaliana genomes suggested 
that most ancestral introns were already of the U2-type (Basu et al., 2008b). Therefore, the 
precise origins of both U2 and U12-type introns remain unresolved, although it is clear that 
both have been present in the early eukaryotic ancestors.  
1.3.4 Significance of U12-type introns 
The apparent ease of loss of U12-type introns in some lineages and their low prevalence 
(0.35% of all introns in humans) might initially suggest that they are merely relics of the past 
that are fading away. However, the fact that they are retained in various highly divergent 
eukaryotes suggests they perform an essential function. It has been noted that U12-type 
introns are excised more slowly than U2-type introns in a wide variety of organisms from 
animals to plants (Patel et al., 2002; Lewandowska et al., 2004; Pessa et al., 2006), giving rise 
to the notion that their removal may be a rate-limiting step in gene regulation. U12-type 
introns generally occur only once in a gene (Burge et al., 1998; Levine and Durbin, 2001), 
suggesting that for such a rate-limiting function, only one U12-type introns is required. 
Furthermore, certain U12-type introns have retained their position in specific orthologous 
genes in distantly related organisms (Burge et al., 1998; Basu et al., 2008a). Together, these 
data suggest that the activity of U12-dependent splicing factors may have a conserved role in 
regulating a specific set of genes in response to external stimuli or in specific tissues or 
developmental stages. Indeed, U12-type intron-containing genes show a bias for being 
differentially expressed in bone marrow CD34 positive cells and B lymphoblast (Yeo et al., 
2007). More importantly, while U12-type introns account for a very small fraction of 
Drosophila melanogaster introns (Schneider et al., 2004; Sheth et al., 2006), U12-dependent 
splicing is nonetheless essential for D. melanogaster development (Otake et al., 2002). U12- 
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type introns are not randomly scattered in genomes, but are most often found in genes that can 
be loosely categorized as information processing genes (Burge et al., 1998; Yeo et al., 2007). 
These genes have functions in DNA replication and repair, transcription, pre-mRNA 
processing, translation and signal transduction, suggesting that the essential function of U12-
dependent spliceosome is linked to the regulation of these genes. However, alterations in U12-
dependent splicing can also have wide effects on multiple downstream processes, as shown by 
the disruption metabolic functions in flies with defective U12-dependent splicing (Pessa et al., 
2010). 
1.4 Spliceosome components 
1.4.1 Components of the U2-dependent spliceosome  
The core components of the major spliceosome include five small nuclear ribonucleoprotein 
particles (snRNPs), each of which contains, and is named after, one of the small nuclear RNAs 
(snRNAs): U1, U2, U4, U5 and U6 (Figure 2). Each snRNA, except U6, contains a binding 
site for Sm proteins, which together form a ring-like core structure for the snRNPs, while U6 
has a similar structure composed of Sm-like (Lsm) proteins (reviewed by Patel and Bellini, 
2008). The snRNPs also contain a varying number of specific protein factors (reviewed by 
Valadkhan and Jaladat, 2010): U1-specific proteins U1A and U1-70K bind directly to U1 
snRNA, while the U1C protein associates through protein-protein interactions (Query et al., 
1989; Scherly et al., 1989; Nelissen et al., 1991; Pomeranz Krummel et al., 2009). In addition 
to the Sm proteins, the core of the U2 snRNP contains the proteins U2A' and U2B'', and is 
complemented by two multiprotein complexes, SF3a and SF3b (Boelens et al., 1990; Brosi et 
al., 1993; Krämer et al., 1999). U4 and U6 snRNAs associate with one another through base-
pairs formed between highly conserved sequence elements (Bringmann et al., 1984; 
Hashimoto and Steitz, 1984), and together with specific proteins form the U4/U6 di-snRNP 
(Nottrott et al., 2002). U5 snRNP associates with U4/U6 through protein-protein interactions 
(Cheng and Abelson, 1987; Konarska and Sharp, 1988; Black and Pinto, 1989), forming the 
U4/U6-U5 tri-snRNP together with additional tri-snRNP-specific protein factors (Behrens and 
Lührmann, 1991; Liu et al., 2006 and references therein). U5 is the largest of the spliceosomal 
snRNPs (Black and Pinto, 1989), and contains several large proteins that make up a significant 
part of the catalytically active spliceosome, most notably the multifunctional protein Prp8 
(reviewed by Valadkhan and Jaladat, 2010).  
In addition to the snRNPs, a number of non-snRNP proteins are also found among the core 
components of the U2-dependent spliceosome, including splicing factor 1 (SF1) and U2 
auxiliary factor (U2AF), which have important functions for recognizing the BPS, PPT and 
3'ss (See chapter 1.5.2). To facilitate the conformational changes occurring during assembly, 
the spliceosome employs a number of peptidyl-prolyl cis/trans isomerases, helicases, kinases 
and other protein and RNA-modifying enzymes, some of which are snRNP components while 
others are non-snRNP proteins (reviewed by Staley and Guthrie, 1998; Smith et al., 2008). 
The spliceosome also interacts with a large number of splicing factors that can suppress or 
  







Figure 2. Secondary structures of spliceosomal snRNAs. 
The predicted secondary structures of the human spliceosomal snRNAs are depicted here schematically. 
The binding sites for Sm proteins are boxed, the sequences interacting with the 5'ss or BPS are marked 
with a black line, and sequences involved in U2/U6 or U12/U6atac basepairing are highlighted in gray. 
Adapted with modifications from Pessa (2010). Structures are as published by Yu et al. (1999) for U1, U2, 
U4, U5 and U6, Tarn and Steitz (1997) for U11, Sikand and Shukla (2011) for U12, and Padgett and 
Shukla (2002) for U4atac and U6atac. 
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enhance splicing at a given site, such as heterogeneous nuclear ribonucleoproteins (hnRNPs) 
and serine-arginine-rich (SR) proteins (see chapter 1.6.4).  Many of the protein factors 
associate with the spliceosome during specific stages of assembly, and can also be specific to 
certain introns or tissues only, making the spliceosome a very dynamic and variable molecular 
machine. It is therefore difficult to pinpoint the exact composition of the spliceosome, and 
estimates for the number of protein components vary between 150 and 300 (reviewed by 
Jurica and Moore, 2003; Valadkhan and Jaladat, 2010). 
1.4.2 Components of the U12-dependent spliceosome 
The U12-dependent spliceosome is similarly composed of five snRNPs, U11, U12, U4atac, 
U5 and U6atac. U5 is therefore a common component of both spliceosomes, and U11, U12, 
U4atac and U6atac are structural and functional counterparts of U1, U2, U4 and U6, 
respectively (Hall and Padgett, 1996; Tarn and Steitz, 1996a, b; Kolossova and Padgett, 1997; 
Yu and Steitz, 1997; Incorvaia and Padgett, 1998). The U12-type snRNAs do not resemble 
their U2-type counterparts in sequence: U11 and U12 are entirely different from U1 and U2 
(Montzka and Steitz, 1988), and U4atac and U6atac share limited (ca. 40%) sequence 
similarity with U4 and U6, respectively (Tarn and Steitz, 1996a). However, the secondary 
structures of the analogous snRNAs are highly similar, highlighting the similarity of their 
functions (Figure 2). 
The low abundance of minor introns is also reflected in the numbers of the minor snRNPs, 
which are approximately 100 times less abundant in human than the major snRNPs (Montzka 
and Steitz, 1988; Tarn and Steitz, 1996a). This has hindered the comprehensive analysis of 
their protein components, and consequently the composition of the minor snRNPs and 
spliceosomal complexes are known in less detail than their major counterparts (see e.g. 
Schneider et al., 2002). However, most of the protein components of the two spliceosomes 
seem to be shared. The minor snRNAs are complexed with Sm or Lsm proteins similarly to 
the major snRNAs (Montzka and Steitz, 1988; Tarn and Steitz, 1996a; Will et al., 1999; 
Schneider et al., 2002). The minor U4atac/U6atac-U5 tri-snRNP also appears to contain most 
if not all of the protein components of the U4/U6-U5 tri-snRNP (Luo et al., 1999; Schneider et 
al., 2002). In contrast to U1 and U2, however, U11 and U12 snRNPs interact with one another 
already before spliceosome assembly, and are mainly present as preformed U11/U12 di-
snRNPs  (Wassarman and Steitz, 1992; see chapter 1.5.4). The protein composition of the 
U11/U12 di-snRNP is also different from that of the U1 and U2 snRNPs: U11/U12 entirely 
lacks U1-specific proteins and the U2-specific SF3a protein complex (Will et al., 1999). 
However, it does contain the SF3b complex and three other proteins present in the major 
spliceosome (YB-1, hPrp43p and Urp), and additionally seven proteins (20K, 25K, 31K, 35K, 
48K, 59K and 65K) specific to the U12-dependent spliceosome (Will et al., 1999; 2001; 
2004). Four of these (25K, 35K, 48K, 59K) are also found in free U11 snRNPs, while three 
appear to associate only with the di-snRNP (Will et al., 2004). Although their functions 
remain undeciphered for the most part, their association with the U11/U12 di-snRNP suggests 
they are involved with 5'ss and BPS recognition and in interactions bridging these two sites 
(see chapter 1.5.5). 
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1.5 Spliceosome assembly and catalysis 
1.5.1 Splicing catalysis 
Both spliceosomes catalyze the same, two-step transesterification reaction that results in the 
formation of an excised intron lariat and ligation of the two exons (Figure 3; reviewed by Will 
and Lührmann, 2011). In the first step, the 2' hydroxyl group of the branch point adenosine 
performs a nucleophilic attack on the phosphate group at the 5'ss, resulting in formation of the 
lariat structure and a free 3' OH group at the end of the upstream exon. This 3' OH then attacks 
the phosphate at the 3'ss, resulting in the ligation of the two exons, and release of the intron 
lariat. Due to its nature as a transesterification reaction, splicing in itself is energetically 
neutral. However, ATP is consumed in many energy-requiring steps during the assembly of 
the spliceosome to ensure the specificity and unidirectionality of the reaction. 
 
 
Figure 3. Catalytic mechanism 
of splicing. 
Splicing occurs through a two-
step transesterification reaction, 
depicted here schematically. 
Intron stucture is depicted as in 
Figure 1A, and additionally the 
reactive phosphates (P) and 
hydroxyl groups (OH) are 
indicated. In the first step of 
splicing, the 2' hydroxyl group of 
the BP adenosine attacks the 5'ss 
phosphate, resulting in the 
formation of a branched intron 
lariat structure, and a free 3' 
hydroxyl in exon 1. In the second 
step, this hydroxyl attacks the 
phosphate at the 3'ss, resulting in 
the ligation of the exons and 




1.5.2 Assembly of the U2-dependent spliceosome 
Unlike another large ribonucleoprotein machinery, the ribosome, the components of the 
spliceosome must undergo a series of complicated rearrangements to become catalytically 
activated (Figure 4). While pre-formed higher order structures of snRNPs have been observed 
in some cases (Konarska and Sharp, 1988; Stevens et al., 2002; Malca et al., 2003), the 
interactions of snRNPs with each other and with the pre-mRNA are generally established in a 
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step-wise manner (Tardiff and Rosbash, 2006; Huranová et al., 2010). The snRNPs are loosely 
associated with the pre-mRNA already at the earliest stages of spliceosome assembly, but their 
interactions with the pre-mRNA are tightly controlled in order to avoid premature and 
unspecific activation of the spliceosome (reviewed by Smith et al., 2008; Wahl et al., 2009). 
The reactive sites in the pre-mRNA are recognized multiple times by RNA or protein factors, 
a process often referred to as proofreading. The recognition events generally depend on 
interactions that are weak on their own, but are stabilized by the combined effects of multiple 
factors. Such intrinsically weak interactions also allow the exchange of binding partners, 
which is crucial for remodeling of the spliceosome at different stages of its assembly. Thus, 
the spliceosome is a highly dynamic molecular machine that undergoes dramatic changes both 
in its composition and its conformation during its maturation. 
The association of snRNPs and other spliceosome components with the pre-mRNA during 
spliceosome assembly are often described in terms of complexes (E, A, B, Bact, B* and C; 
Figure 4) that can be separated by biochemical methods (reviewed by Will and Lührmann, 
2011). The initial step in intron recognition is the formation of the commitment (or E) 
complex, during which U1 snRNP binds to the 5'ss sequence. U1 snRNA base-pairs to the 5'ss 
through a complementary sequence at its 5' end (Zhuang and Weiner, 1986), and this 
interaction is stabilized by protein-RNA interactions, most significantly by the U1C protein, 
which stabilizes the 5'ss/U1 helix (Heinrichs et al., 1990; Pomeranz Krummel et al., 2009). 
During this stage, the BPS is recognized by the protein factor SF1 (Berglund et al., 1997), 
which defines the catalytically functional adenosine such that it bulges out of the structure 
(Liu et al., 2001), making it available for the subsequent nucleophilic attack in the later stages 
of spliceosome maturation. At the same time, the PPT is recognized by the 65 kDa subunit of 
U2AF (Zamore and Green, 1989), while its 35 kDa subunit interacts with the 3'ss (Guth et al., 
1999; Wu et al., 1999; Zorio and Blumenthal, 1999).  
Although the U2 snRNP is already present in the E complex and in proximity to U1 (Dönmez 
et al., 2007), it becomes stably associated with the BPS in the ATP-dependent A complex, 
also known as the prespliceosome (Bindereif and Green, 1987; Liao et al., 1992). During the 
formation of the prespliceosome, U2AF recruits U2 snRNP to the BPS through interactions 
with the SF3b complex, displacing SF1 (Ruskin et al., 1988; Valcárcel et al., 1996; Gozani et 
al., 1998; Rutz and Séraphin, 1999; Spadaccini et al., 2006; see also Figure 4). Thus, in a 
proofreading event typical of the spliceosome, the task of defining the BP is transferred from 
SF1 to U2 snRNP. U2 snRNA associates with the BPS through base-pairing interactions (Wu 
and Manley, 1989; Zhuang and Weiner, 1989), which exclude the reactive adenosine (Query 
et al., 1994), therefore retaining the bulged conformation. The specific recognition of the BP 
is additionally mediated by proteins of the SF3b complex, which together with the SF3a 
complex is also involved in stabilizing U2 binding to the BPS and to U2AF (Gozani et al., 
1996; 1998; Spadaccini et al., 2006).  
 





Figure 4. Spliceosome assembly. 
The interactions of the spliceosomal snRNPs and some selected non-snRNP protein complexes at various 
stages  of spliceosome assembly are depicted schematically for both the U2-dependent and U12-
dependent spliceosomes, as indicated above the panel (see chapter 1.5 for details). Complexes E, A, B* 
and C are indicated in the middle.The Prp19/CDC5 complex is indicated by "19C". The association and 
dissociation of certain protein complexes is not known in detail for the U12-dependent spliceosome, and 
such events are marked with question marks. 
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The U4/U6-U5 tri-snRNP is also present already in the E complex, with the U5-specific 
protein Prp8 in direct contact with the 5'ss (Maroney et al., 2000). However, compositional 
and conformational changes during B complex formation lead to the stable association of 
U4/U6-U5 tri-snRNP (Konarska and Sharp, 1987; Lamond et al., 1988), followed by a 
number of significant rearrangements in RNA-RNA interactions to yield the pre-catalytic Bact 
complex: In another significant proofreading event, U1 is displaced from the 5'ss, which 
instead becomes base-paired to U6 (Kandels-Lewis and Séraphin, 1993). The helices between 
U4 and U6 snRNAs unwind and U4 snRNP is released from the spliceosome (Konarska and 
Sharp, 1987; Lamond et al., 1988). U6 base-pairs to U2, forming RNA structures necessary 
for splicing catalysis (Wu and Manley, 1991; Madhani and Guthrie, 1992). U5 snRNA is not 
involved in sequence-specific base-pairing interactions, but seems to stabilize spliceosome 
structures by binding to both exons via its U-rich loop structure (Newman and Norman, 1992; 
Sontheimer and Steitz, 1993). 
Interactions between the snRNAs are not the only ones to be remodeled at this stage. Many of 
the snRNP proteins dissociate, including all those of U1, U4 and U6, as well as a number of 
non-snRNP proteins (Bessonov et al., 2008; Fabrizio et al., 2009; Agafonov et al., 2011). The 
spliceosome is also joined by a number of factors, including the Prp19/CDC5 complex, which 
is involved in rearranging many protein-protein and protein-RNA interactions, particularly 
those of U5 and U6 (Makarov et al., 2002; Chan et al., 2003; Makarova et al., 2004). These 
changes eventually yield the activated spliceosome, or complex B* (Figure 4). The U5-
specific Prp8 protein likely functions as a crucial platform for the catalytic core, as it forms a 
network of interactions with the catalytically active sites during the maturation of the 
spliceosome, eventually interacting with both splice sites and the BPS, as well as U5 and U6 
snRNAs (reviewed by Grainger and Beggs, 2005). After the first catalytic step, the SF3a and 
SF3b complexes of U2 snRNP dissociate, and the spliceosome is joined by further factors, 
including specific helicases and peptidyl-prolyl cis/trans isomerases (Bessonov et al., 2008; 
Fabrizio et al., 2009; Agafonov et al., 2011). These likely facilitate the conformational 
changes required for formation of complex C, which catalyzes the second catalytic step. 
1.5.3 Is the spliceosome a ribozyme? 
The similarities between the spliceosome and self-splicing group II introns suggest that it may 
also be an RNA enzyme (see chapter 1.2.2.3). Multiple lines of evidence suggest that U6 
snRNA has a crucial role in the catalytic center. All U6-specific proteins, as well as the U4 
snRNP, are released during the maturation of the catalytic spliceosome (Bessonov et al., 2008; 
Agafonov et al., 2011), suggesting that their function is merely to escort U6 snRNA into the 
catalytic core. Moreover, the binding of Mg2+ ions by U6 has been implicated in catalysis 
(Yean et al., 2000; Lee et al., 2010), and the first step of splicing takes place in the vicinity of 
an invariant sequence of U6 (reviewed by Valadkhan, 2010). Most strikingly, U2 and U6 
snRNAs can catalyze a two-step splicing reaction between short oligonucleotides in the 
absence of proteins (Valadkhan et al., 2009). However, it is clear that proteins play significant 
roles for the specificity, efficiency and fidelity of the spliceosome. Recent evidence also 
suggests that protein components of the spliceosome, particularly Prp8 and its RNase H-like 
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domain, might be involved in the catalysis itself (reviewed by Abelson, 2008). It is likely that 
both proteins and RNA contribute to the catalytic activity, but the question remains unresolved 
for the time being. 
1.5.4 Assembly of the U12-dependent spliceosome 
The overall assembly pathways in the two spliceosomes are similar (reviewed by Patel and 
Steitz, 2003). However, the initial recognition of U12-type introns differs from that of U2-type 
introns (Figure 4). The preformed U11-U12 di-snRNPs bind the intron as a unit, and the 5'ss 
and BPS are recognized in a co-operative manner, although U11/5'ss base-pairing can still be 
detected prior to stable base-pair formation between U12 and the BPS (Frilander and Steitz, 
1999). Consequently, the first observed complex for U12-type introns in native gels is the 
ATP-dependent A complex (Tarn and Steitz, 1996b; Frilander and Steitz, 1999; Figure 4). 
U12-type introns do not have PPTs, and U2AF is not required for the recognition of U12-type 
introns (Shen and Green, 2007). However, a U2AF35-related protein, Urp, is required for A 
complex formation and 3'ss recognition (Shen et al., 2010). Interestingly, Urp is also required 
for U2-dependent splicing, but only after the first catalytic step, when it apparently displaces 
U2AF from the PPT and 3'ss (Shen et al., 2010), suggesting that the U2-type 3'ss is proofread 
several times by protein factors. In contrast, the lack of PPT, more conserved recognition 
sequences and more restricted BPS-3'ss distance (Figure 1) suggest that the recognition of 
U12-type introns relies more on RNA-RNA interactions, and protein-mediated proofreading is 
less important (Brock et al., 2008). 
As stated above (chapter 1.4.2), due to the low abundance of U12-type factors, our 
understanding of the specific interactions during minor spliceosome assembly is less complete 
than for the major spliceosome. However, despite the differences in intron recognition, it 
seems that the steps leading to catalytic core formation are similar to those of the major 
spliceosome (Figure 4). The U12/BPS duplex is highly analogous to the U2/BPS duplex, 
causing the bulging of the reactive adenosine (Tarn and Steitz, 1996b). The SF3b complex 
associates with U12 as well as U2 snRNPs, and helps to define the BPS in both spliceosomes 
(Gozani et al., 1996; Will et al., 2001; 2004). Upon formation of the B complex, the 
U4atac/U6atac/U5 tri-snRNP joins the forming spliceosome, leading to the displacement of 
U11 from the 5'ss by U6atac, which also base-pairs to U12, with the concomitant release of 
U4atac (Tarn and Steitz, 1996a; Yu and Steitz, 1997; Incorvaia and Padgett, 1998). The 
modifications taking place in the RNA-RNA interaction network are similar to those of the 
major spliceosome, but the order of events appears to be somewhat more flexible in the minor 
spliceosome (Frilander and Steitz, 2001). The active spliceosome then catalyses the two-step 
transesterification reaction, resulting in ligation of the exons and release of the intron lariat 
(Tarn and Steitz, 1996b; see Figures 3 and 4). Due to the identical chemistries of the splicing 
reactions, the catalytic cores of the two spliceosomes are likely to be similar. In support of 
this, the functional domains of U6 and U6atac snRNAs are highly similar, and are functional 
in splicing when replaced with one another  (Shukla and Padgett, 2001). 
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1.5.5 Comparison of initial intron recognition in the two spliceosomes 
The absence of U2AF and SF1, as well as the lack of an E complex during U12-dependent 
prespliceosome assembly, have led to the suggestion that recognition of the minor introns 
relies more on snRNA-RNA interactions, and requires less proofreading by protein factors 
than recognition of major introns (chapter 1.5.4; for discussion, see also Patel and Steitz, 
2003). This may also be the consequence, at least partially, of the co-operative recognition of 
the minor 5'ss and BPS by the preformed U11/U12 di-snRNP (Frilander and Steitz, 1999), 
which imposes more stringent requirements on sequence recognition. However, snRNAs are 
not alone in recognizing the splice sites in the minor prespliceome. As mentioned above 
(chapter 1.5.4), proteins factors of the SF3b complex are involved in recognition of the U12-
type BPS, although the SF3a complex present in the U2-type prespliceosome is absent (Will et 
al., 1999; 2004). Interestingly, in contrast to major prespliceosome, the first three nucleotides 
of the U12-type introns (RUA; see Figure 1B) are not recognized by snRNAs at all, 
suggesting that specific protein factors are involved (see chapter 4.1). In the major 
spliceosome, the 5'ss/U1 helix spans the exon-intron junction, and is stabilized by interactions 
with the U1C protein. It has been noted that the U11/U12-20K protein has sequence similarity 
with U1C (Will et al., 2004), but no interaction with the 5'ss and the 20K protein has been 
observed. U1/5'ss interactions are also stabilized by SR proteins, particularly SRSF1, which 
binds directly to the U1-70K protein (see chapter 1.6.4.1). The U11-35K protein shares 
similarity with U1-70K (Will et al., 1999), and both have been observed to interact with the 
homologs of SRSF1 in Arabidopsis thaliana (Lorković et al., 2004), suggesting that 5'ss 
recognition can be enhanced by similar mechanisms in both spliceosomes. 
SR proteins have been shown to interact with both the 5'ss and BPS in both spliceosomes 
(Shen and Green, 2006, 2007), and may thus contribute to interactions that bring these two 
sites together. However, in the minor prespliceosome, the internal components of the U11/U12 
di-snRNP are obviously involved in bridging the 5'ss and the BPS (Benecke et al., 2005; I). 
Interestingly, the catalytically active 5' end of U12 is also brought close to the 5'ss during 
prespliceosome formation, suggesting that major rearrangements in the conformation of U12 
are not necessary at later stages of spliceosome assembly (Frilander and Meng, 2005). 
Similarly, the U2-type 5'ss is in proximity to both the BPS and U2 already in the E complex, 
before U2 base-pairs to the BPS (Kent and MacMillan, 2002; Dönmez et al., 2007). The 5' 
region of U2 snRNA has been shown to be close to the stem-loop SL3 of U1 snRNA, 
suggesting it might function as a binding platform for U2 snRNP (Dönmez et al., 2007; Weber 
et al., 2010). However, a number of non-snRNP proteins, including Prp5, have also been 
implicated in bridging U1 and U2 snRNPs (Xu et al., 2004; Shao et al., 2011), indicating that 
internal snRNP components are not sufficient for intron bridging in the major spliceosome. It 
is likely that these differences in intron recognition are used by spliceosome-specific 
regulatory mechanisms to control their activity. 
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1.6 Splice site definition and alternative splicing 
1.6.1 Initial splice site definition over exons 
In many multicellular eukaryotes, especially vertebrates, primary transcripts are mainly 
composed of intronic sequences, and some of the introns may be hundreds of kilobases long. 
This poses the splicing machinery with a difficult problem of correctly pairing splice sites that 
are separated by huge distances. On the other hand, vertebrate exons are generally rather short, 
suggesting that the initial splice site pairing in organisms with long introns in fact takes place 
over exons (Figure 5; reviewed by Berget, 1995). Indeed, 3'ss-recognizing factors of the 
upstream intron can interact with the 5'ss-recognizing factors of the downstream introns 
(Robberson et al., 1990; Hoffman and Grabowski, 1992), and long exons flanked by long 
introns are recognized poorly (Sterner et al., 1996; Fox-Walsh et al., 2005). Such exon 
definition interactions are later replaced with interactions that pair the splicing factors within 
the same intron. The final splice site pairing generally takes place in the A complex (Lim and 
Hertel, 2004; see also Figure 4), but apparently the process is flexible, as direct conversion of 
exon-defined complexes into B complexes has also been observed (Schneider et al., 2010).  
Exon definition appears to be particularly important in mammals. The most common form of 
aberrant splicing in mammals is exon skipping (Nakai and Sakamoto, 1994), which is 
consistent with pairing of splicing factors located at the upstream and downstream exon, when 
defining the middle exon fails. The importance of exon definition in mammals is also apparent 
by the fact that mutations weakening one splice site flanking an exon are often compensated 
by mutations strengthening the other (Xiao et al., 2007). In contrast, in organisms with shorter 
introns, such as plants, fungi and many invertebrates, compensatory mutations generally occur 
within the same intron (Xiao et al., 2007), suggesting that shorter introns are defined directly, 
as also experimentally observed for mammalian introns by Sterner et al. (1996) and Fox-
Walsh et al. (2005). 
1.6.2 Splicing enhancers and silencers 
Due to their short length and, especially in U2-type introns, degenerate nature, the core 
splicing signals within introns are not sufficient for unambiguous definition of splice sites 
(Burge et al., 1999; Lim and Burge, 2001). Furthermore, true U2-type 5'ss signals are 
outnumbered many-fold by similar, non-functional splice sites (pseudo splice sites), and are 
often found in positions where they could define putative exons (pseudoexons) with upstream 
3'ss-like sequences. Thus, the correct activation of splice sites requires additional information, 
which is provided by enhancer or silencer sequences in the vicinity of the splice sites (Figure 
5). They are categorized based on their location into exonic splicing enhancers (ESEs) or 
silencers (ESSs) or intronic splicing enhancers (ISEs) or silencers (ISSs). Although each of 
these splicing regulatory element (SRE) subtypes has some typical characteristics, they are 
composed of short and variable sequences. As they can function in combinations, and either in 
a co-operative or antagonistic manner, their effects on splicing are highly dependent on 
context, and are difficult to predict based on sequence information alone (for review, see 
Wang and Burge, 2008). However, large-scale bioinformatic studies have provided 
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information about SRE distributions in true exons and pseudoexons, and the effect of short 
sequence motifs on splicing in vitro and in vivo has been tested experimentally by selective 
molecular evolution methods (reviewed by Chasin, 2007). Most promisingly, some progress 
has recently been made in this field by using computational methods to analyze and predict 
alternative splicing patterns in different tissues (Barash et al., 2010). Among other things, this 
study revealed that alternative splicing is affected by intronic sequence elements located much 
further away (250–300 nt) from splice sites than previously thought.  
While it has been established that the more conserved U12-type introns do contain enough 
information to be recognized correctly in a given transcript, their presence in only a handful of 
transcripts means that specifying their unique location within all transcripts requires additional 
information (Burge et al., 1999). Accordingly, they also respond to regulation by SREs (Wu 
and Krainer, 1998; Hastings and Krainer, 2001; Lewandowska et al., 2004), and U12-
dependent splicing is enhanced by exon definition interactions with U2-type factors in 
neighbouring introns, and vice versa (Wu and Krainer, 1996; Lewandowska et al., 2004; II).  
 
Figure 5. Splicing regulatory elements and splice site definition. 
Splicing is regulated by trans-acting factors that bind to enhancer and silencer elements. These are also 
involved in bringing together spliceosomal components bound at the 5'ss and 3'ss, either through exon 
definition or intron definition interactions. Exons and the regulatory elements (ESEs, ESSs) within them are 
depicted as boxes, and introns and their regulatory elements (ISEs, ISSs) by lines. Interactions between 
splicing factors are depicted schematically, with arrows representing activating interactions, and blocked 
lines representing inhibitory interactions. See chapter 1.6 for details. 
1.6.3 Alternative splicing increases proteome complexity 
Regulation of splicing by SREs is important not only for distinguishing true exons from 
pseudoexons, but also for producing alternatively spliced mRNAs. Alternative splicing is the 
most significant mechanism for increasing proteome diversity, accounting for most of the 
estimated 5-fold excess of proteins over protein-coding genes in humans (reviewed by Nilsen 
and Graveley, 2010). In fact, it is utilized by almost all protein-coding genes, as recent studies 
indicate that 92–95 % of human multi-exon pre-mRNAs are spliced to produce at least two 
abundant isoforms (Pan et al., 2008; Wang et al., 2008). A typical case of alternative splicing 
in mammals involves the inclusion or exclusion of an alternative cassette exon (Figure 6C), 
reflecting the importance of exon definition interactions in these organisms (see chapter 1.6.1). 
Other, slightly less common modes of alternative splicing include use of alternative 5'ss or 
3'ss, mutually exclusive exons or intron inclusion (Figure 6A, 6B, 6D and 6E, respectively). 
Thus, the majority of alternative splice site choices seem to take place between competing 
splice sites during formation of the commitment complex, either through exon definition or 
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intron definition. However, it has been shown that alternative splicing can also be affected 
during the transition from exon-defined complexes to intron-defined spliceosomes, so that 
exons already defined by splicing factors are nonetheless excluded from the mRNA. This can 
occur either through hyperstabilization of exon-defined complexes such that they cannot pair 
with other splicing complexes over introns, or by selectively inhibiting or enhancing the 
formation of intron definition interactions between specific exon-defined complexes (House 
and Lynch, 2006; Bonnal et al., 2008; Sharma et al., 2011). Other mechanisms during later 
steps are also occasionally involved, such as formation of stalled complexes (Lallena et al., 
2002; Giles and Beemon, 2005). 
While different types of SREs are utilized for both 
constitutive and alternative splicing, certain differential 
patterns can be observed in genome-wide studies. 
Enhancing elements are expected to be important for 
efficient and precise splicing of constitutive exons, and 
ESEs are indeed enriched in constitutive exons, and are 
particularly underrepresented in pseudoexons (Wang et al., 
2005). ESSs also have an important role in distinguishing 
true exons from pseudoexons, but additionally function in 
regulating alternative splice site selection and intron 
retention (Wang et al., 2004; 2006). Intronic SREs are 
likely to have particularly important functions for 
alternative splicing control, as intronic regions 
surrounding alternative exons are far more conserved than 
those surrounding constitutive exons (Sorek and Ast, 
2003). 
Figure 6. Types of alternative splicing. 
Various types of alternative splicing are depicted schematically. Constitutive exonic sequences in the pre-
mRNA are represented by the darker rectangles, and the intronic regions by lines. The light rectangles 
represent regions that can be either excluded or included in the mature mRNA, as indicated by the lines 
above and below the pre-mRNA. A) Splicing at alternative 5' splice sites. B) Splicing at alternative 3' splice 
sites. C) Alternative cassette exon (i.e. exon skipping or inclusion). D) Mutually exclusive exons. E) Intron 
retention. 
1.6.4 Trans-acting factors affecting splice site choice 
Although some SREs can affect splicing directly, e.g. through formation of specific RNA 
secondary structures (reviewed by Buratti and Baralle, 2004), most SREs function by 
recruiting trans-acting factors that either stimulate or suppress splicing (Figure 5). Thus, the 
effect of the SREs does not depend solely on their presence in the transcript, but also on the 
availability of different trans-acting factors, which varies in different cell types and 
developmental stages, giving rise to different splicing isoforms. There are various kinds of 
trans-acting factors, from riboswitch-binding small molecule ligands to small nucleolar RNAs 
(snoRNAs) and snRNPs (reviewed by Khanna and Stamm, 2010), but the most extensively 
characterized and possibly most common regulators of splicing are protein factors. They 
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generally bind to SREs through their RNA-binding domains, many different types of which 
have been described, including the RNA recognition motif (RRM), hnRNPK homology (KH) 
domain and zinc-binding domains (reviewed by Auweter et al., 2006). In most cases, these 
domains recognize specific sequences in ssRNA, although certain domains, such as some 
RRMs, can show considerable flexibility in their target sequences. This is achieved through 
the recognition of a few specific bases by the RRM, which stabilizes the binding through non-
specific interactions with RNA. Thus, while clear binding sites can be discerned for some 
splicing factors, many of them can bind to a wide variety of targets, increasing the complexity 
of alternative splicing. The final splice site selection is often decided through the co-operative 
and competitive actions between different splicing regulators. The best known regulators 
belong to one of two significant groups of proteins, the SR proteins and hnRNP proteins, 
which often, but not always, have antagonizing effects on splice site selection (Figure 5).   
1.6.4.1 SR proteins 
SR (serine-arginine-rich) proteins form a multi-functional group of proteins that operate in 
various steps of gene expression, from chromatin remodeling to mRNP transport and 
translation regulation (reviewed by Zhong et al., 2009). SR proteins are structurally related, 
each of them having at least one N-terminal RRM and a downstream arginine-serine-rich (RS) 
domain (Manley and Krainer, 2010). Additionally, a large number of SR-like proteins contain 
RS domains, although they may lack the RRM domains and instead contain different RNA-
binding domains or other functional domains (reviewed by Long and Caceres, 2009).   
Many constitutive splicing factors are SR proteins or SR-like proteins, including U2AF65, 
U2AF35, Urp and U1-70K. However, most SR proteins are perhaps best known for their 
functions as splicing activators in both constitutive and alternative splicing, typically 
functioning through binding to ESEs (reviewed by Blencowe, 2000). SR proteins stimulate 
recruitment of splicing factors to nascent transcripts during transcription (Das et al., 2007), 
and are required for committing pre-mRNA to the splicing pathway (Fu, 1993). Many SR 
proteins directly interact with core spliceosomal components and stabilize their binding, and 
they are essential for bridging the 5'ss and 3'ss in U2-type introns as well as mediating 
bridging interactions needed for exon definition (Boukis et al., 2004). A well-characterized 
ESE-binding SR protein with multiple functions is SRSF1 (also known as ASF/SF2), which 
enhances binding of U1 snRNP to the 5'ss (Kohtz et al., 1994; Cho et al., 2011), and also 
interacts directly with the RNA at the BPS as well as with U2AF35 at the 3'ss (Wu and 
Maniatis, 1993; Shen and Green, 2004; Shen et al., 2004). SR proteins are additionally 
involved in recruiting the U4/U6-U5 tri-snRNP (Roscigno and Garcia-Blanco, 1995; 
Makarova et al., 2001). The recognition of the U12-type 5'ss and BPS by the U11/U12 di-
snRNP is also promoted by SR proteins, and they directly contact U12-type introns during 
spliceosome assembly (Hastings and Krainer, 2001; Shen and Green, 2007).  
Another way in which SR proteins stimulate splicing is to counteract the effect of inhibitory 
factors such as hnRNPs by either competing for binding sites or by blocking interactions 
required for silencing (see e.g. Zhu et al., 2001; Crawford and Patton, 2006). Such 
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competition between splicing activators and suppressors is particularly important in alternative 
splicing. SR proteins can also change alternative splicing patterns by competing with each 
other, such that different SR proteins promote inclusion of different exons (Gallego et al., 
1997; Jumaa and Nielsen, 1997; Han et al., 2011). Similar to other splicing regulators, the 
functions of SR proteins are context-dependent, and SR proteins with known functions in 
ESE-dependent splicing activation, including SRSF1, can also recognize ISSs and suppress 
inclusion of alternative exons (Kanopka et al., 1996; Jiang et al., 1998; Buratti et al., 2007b). 
An important mechanism for regulating the activities of SR proteins is phosphorylation at the 
serine residues of their RS domains. Such regulation is particularly important for the 
regulation of alternative splicing, as it enables changes in alternative splicing patterns in 
response to external stimuli, through kinase-mediated signaling cascades (reviewed by Lynch, 
2007). Phosphorylation can also influence constitutive splicing. Phosphorylation of the RS 
domain of SRSF1 is required for a conformational switch, which enables the SRSF1 RRM 
domain bound to an ESE to also interact directly with the RRM domain of U1-70K, enhancing 
5'ss recognition (Cho et al., 2011). Conversely, dephosporylation of both SRSF1 and U1-70K 
is required for the catalytic step of splicing (Tazi et al., 1993; Cao et al., 1997). 
1.6.4.2 HnRNP proteins 
Heterogeneous nuclear RNP (hnRNP) proteins are another well-known group of splicing 
regulators. Like SR proteins, they are also involved in various other processes, including DNA 
repair, chromatin remodeling, transcription and mRNP export (reviewed by Han et al., 2010). 
However, in contrast to SR proteins, they do not form a structurally unified group with similar 
domain structures. Some of them contain RRM domains, similar to SR proteins, but others 
contain RNA-binding domains that are structurally distinct from the RRM domain, such as the 
KH domain. Some hnRNPs also contain RS domains, and the distinction between hnRNPs and 
SR or SR-like proteins may in some cases be considered merely the result of a historical co-
incidence, reflecting a presumed divide into activators and suppressors of splicing. Similar to 
SR proteins, hnRNPs are subject to modifications that regulate their functions. They undergo a 
variety of post-translational modifications, including phosphorylation and methylation. The 
production of different isoforms by alternative splicing is also widespread among hnRNPs, 
reflecting their varied functions. Many such isoforms are also specific to certain organisms or 
tissues or developmental phases. 
Although hnRNPs have previously been regarded as splicing suppressors, it has become 
evident that their functional properties are as varied as their structures. For example, proteins 
of the hnRNPA/B family are well known for antagonizing the effects of SR proteins in 
splicing activation and promoting exon skipping (reviewed by Han et al., 2010). A member of 
this family, hnRNPA1, has been shown to induce exon skipping by forming homodimers with 
the individual proteins bound on either side of the exon, thus making the exon unavailable to 
the splicing machinery (Chabot et al., 1997; Han et al., 2005). However, the same mechanism 
can also be employed to enhance exon inclusion by two hnRNPA/B molecules bound within 
an intron, which upon dimerizing bring together the two ends of the intron and promote 
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splicing (Martinez-Contreras et al., 2006). HnRNPA/B proteins can also form similar bridging 
dimers with other hnRNPs, including members of the hnRNPF/H protein family (Martinez-
Contreras et al., 2006; Fisette et al., 2010; see the following chapter). In addition to altering 
the RNA architecture, hnRNPs are also known to compete directly with spliceosome 
components. This is the case with hnRNPF/H proteins (see following chapter), and PTB 
(polypyrimidine tract binding protein, also known as hnRNPI), which binds to PPT, occluding 
binding of U2AF (Matlin et al., 2007). Similar to hnRNPA/B proteins, several PTB molecules 
also often bind on both sides of exons (Xue et al., 2009), and PTB interferes with the 
transition from exon-defined complexes to intron-defined complexes by binding next to the 
5'ss and interacting directly with U1, thus blocking its interactions with splicing factors 
downstream (Sharma et al., 2008; Sharma et al., 2011). 
1.6.4.3 G-run motifs and the hnRNPF/H protein family 
Most hnRNPs have highly degenerate consensus binding sites. However, the members of the 
hnRNPF/H protein family have a fairly defined target sequence, centered around a G-run 
motif, DGGGD (where D is A or G or U) (Caputi and Zahler, 2001; Schaub et al., 2007). This 
family is composed of five structurally related proteins known as hnRNPs F, H1 (or H), H2 
(H'), H3 (2H9) and GRSF-1. Their RNA-binding domains resemble the canonical RRM 
domains, but have different folds, and have therefore been named quasi-RRMs (qRRMs; 
Honoré et al., 1995). Like many hnRNPs, the members of the hnRNPF/H protein family are 
present in many alternatively spliced isoforms, some of which lack some or all of the qRRMs, 
suggesting that they may have variable functions in splicing as well as in other processes 
(Honoré, 2000). Each member of the hnRNPF/H group can bind to the G-run motif on its own 
in vitro, but they can also form aggregates with each other (Schaub et al., 2007). The members 
of the protein family also have variable functions, some of which appear to be redundant, 
while others are specific. For example, ESS-bound hnRNPF/H can in certain cases repress the 
inclusion of an exon in a redundant manner (Crawford and Patton, 2006; Mauger et al., 2008; 
Coles et al., 2009), while in other systems the repression takes place with hnRNPH1 and/or 
H2, but not with hnRNPF (Buratti et al., 2004; McNally et al., 2006). Such differences may be 
essential in defining alternative splicing patterns in different tissues, as hnRNPH1 levels vary 
greatly from one tissue to another (Honoré et al., 2004). Also, while hnRNPs F, H1 and H2 
are each found in both the nucleus and the cytoplasm, hnRNPs H1 and H2 are primarily 
nuclear, and hnRNPF is more abundant in the cytoplasm (Matunis et al., 1994; Honoré et al., 
2004). 
Similar to other SREs, the functions of the G-run motif are context-dependent. Exonic G-runs 
generally function as ESSs, while intronic G-runs are ISEs, and are particularly prevalent 
downstream of 5'ss sequences (Xiao et al., 2007; Xiao et al., 2009). Evolutionary studies have 
shown that strengthening such G-run ISEs compensates for weakened 5' splice sites (Xiao et 
al., 2007). Activation of 5' splice sites by ISE-bound hnRNPH1 has been observed in both U2 
and U12-type introns (Han et al., 2005; McNally et al., 2006; Wang and Cambi, 2009). A 
large-scale RNA interference (RNAi) knockdown experiment revealed that hnRNPH1 
activates splicing of introns with G-run ISEs, particularly introns with intermediate strength 
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5'ss sequences, suggesting hnRNPH1 can act as a buffer for splice site mutations (Xiao et al., 
2009). In contrast, the effects of hnRNPH1 as an ESS-bound repressor were strongest on 
exons with strong or weak 5' splice sites.  
While these results show that the G-runs and hnRNPH1 (and other hnRNPF/H proteins) have 
widespread functions in splicing regulation, less is known about the precise molecular 
mechanisms affecting splicing. At least in some cases, G-run ISEs and hnRNPF/H proteins 
enhance U1 binding to the 5'ss (Wang and Cambi, 2009), while in other cases they enhance 
spliceosome assembly during the formation of the A-complex, but not during the initial U1 
binding (Schaub et al., 2007). The enhancing or suppressing effect of G-runs has also been 
attributed to formation of cross-intron or cross-exon hnRNPH1 homodimers or 
hnRNPH1/hnRNPA1 heterodimers (Martinez-Contreras et al., 2006; Fisette et al., 2010). In 
many cases the G-run ESSs are located close to one of the splice sites, suggesting steric 
competition with splicing factors (Jacquenet et al., 2001; Buratti et al., 2004; LeFave et al., 
2011). HnRNPF/H proteins have also been shown to repress splicing by directly competing 
with other splicing factors, such as SR proteins (Crawford and Patton, 2006; Mauger et al., 
2008).  
1.6.4.4 Core spliceosomal components as splicing regulators 
Originally, alternative splicing was thought to be regulated by auxiliary splicing factors, such 
as SR proteins and hnRNPs. However, it has become clear that the levels and activity of core 
spliceosomal factors can also affect splicing patterns. In an RNAi screen of Drosophila 
melanogaster splicing factors, several core spliceosomal factors were identified as alternative 
splicing factors, including U2AF and components of U1, U2 and U4/U6 snRNPs (Park et al., 
2004). Also in human cells, depletion of U2AF65 and its homologue PUF60 resulted in 
altered splicing patterns (Hastings et al., 2007), and depletion of the common snRNP-
component SmB/B' resulted in changes in splicing of alternative exons, but not constitutive 
exons (Saltzman et al., 2011). The depletion particularly affected U1 snRNPs, and the 
alterations in alternative splicing patterns were most likely caused by competition between 5' 
splice sites, with strong splice sites being favoured over weak ones. Specific changes in 
alternative splicing patterns were also observed after the depletion of the U1C protein in 
zebrafish (Rösel et al., 2011).  
Among core spliceosome components, U1 appears to be a particularly prevalent regulator of 
alternative splicing. U2-type 5'ss-like sequences were found as potent suppressors of 
pseudoexon splice sites in a screen for exonic splicing silencers (Wang et al., 2004), and 
constituted as much as 17% of elements downstream of exons in a screen for intronic SREs 
(Yeo et al., 2007). Pseudoexon repression has been found in the transcripts of the ATM gene, 
where U1 suppresses exon inclusion by binding to an ESS close to the 3'ss and promoting 
unstable binding of U2 upstream (Dhir et al., 2010). Inhibition of true 5' splice sites by U1-
binding upstream has also been observed, and is most likely caused by steric hindrances 
(Siebel et al., 1992; Cloutier et al., 2008). U1 binding to intronic SREs has been associated 
with activation of an upstream 5'ss (McCullough and Berget, 2000). In this case, U1 
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recognized the ISEs through base-pairing interactions that did not resemble the canonical 
U1/5'ss base-pairing. Interestingly, U1 also appears to affect processes other than splicing, as 
suggested by a recent report showing widespread suppression of premature polyadenylation 
sites by U1 (Kaida et al., 2010). 
Multiple snRNPs can be involved in splicing regulation, as exemplified by the gag gene of 
Rous sarcoma virus (RSV; reviewed by McNally, 2008).  In this system, a pseudo-intron 
resides within an authentic intron, and a full complement of U2-type snRNPs assembles on it. 
However, the spliceosome assembly is defective, and splicing does not occur. Instead, the 
defective complex also suppresses the splicing of the authentic intron, possibly by preventing 
formation of cross-intron interactions. This inhibition can be reversed by binding of U11/U12 
di-snRNP or U11 snRNP at a U12-type pseudo-5'ss overlapping the U2-type pseudo-5'ss. This 
also does not lead to U12-dependent splicing, but prevents binding of U1 at the pseudo-5'ss 
and permits splicing of the authentic intron. Multiple factors further regulate these events, with 
SR proteins promoting U1 binding, while hnRNPH1 promotes U11 binding. 
1.6.4.5 Complex splicing regulatory elements 
In the study of alternative splicing, SREs are in most cases viewed as single building blocks, 
which bind either repressing or activating factors, with the sum of all SRE-protein interactions 
defining the alternative splicing pattern. This view has been influenced by the fact that the 
effects of simple SREs, when present, are naturally much easier to detect than those of highly 
complex SREs, which may bind competing factors that only cause subtle effects on splicing. 
Complex regulatory elements have been observed in several systems, including the chicken 
cTNT exon 5 (Ladd et al., 2005), and the human c-src exon N1 (Chou et al., 2000; Sharma et 
al., 2005) and CFTR exons 9 and 12 (Pagani et al., 2003a, b). The CFTR exon 12 is almost 
entirely covered with splicing regulatory elements, including complex CERES elements 
(composite exonic regulatory elements of splicing) (Haque et al., 2010). These elements are 
less than 10 nt long, but are recognized by a large number of competing factors, including 
SRSF1 and SRSF6 and hnRNPs A1, A2, C2 and U, and mutations within these elements can 
affect the binding of several factors at once, resulting in rather unpredictable splicing patterns 
(Haque et al., 2010).  
1.6.4.6 Other factors affecting alternative splicing 
As mentioned in the previous chapters, the availability of splicing factors can affect splice site 
choice. The distribution of splicing factors within a cell is therefore an important factor 
regulating splicing (reviewed by Nilsen and Graveley, 2010). Due to its co-transcriptional 
nature, splicing is also affected by kinetic factors linked to transcription. Pausing of RNAPII 
at exons has been observed, and such changes in the speed of RNAPII may favour certain 
splicing events over others (reviewed by Nilsen and Graveley, 2010; Carrillo Oesterreich et 
al., 2011), and affect RNA secondary structure, which in turn has been shown to affect 
splicing, e.g. by masking splice sites (Buratti et al., 2007a; Yu et al., 2008). 
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Most intriguingly, it has recently been shown that chromatin structure can also affect splicing. 
Although the causal relationship between chromatin modifications and splicing still remains 
unclear, several lines of evidence suggest that the two processes are linked: The average size 
of exons closely correlates with the average length of DNA bound by a mononucleosome, 
nucleosomes are subtly enriched in exons vs. introns, and methylation of the lysine 36 residue 
of histone 3 (H3K36me3) shows similar distribution (reviewed by Schwartz and Ast, 2010). 
SR proteins can interact directly with chromatin (Kress et al., 2008; Loomis et al., 2009), and 
PTB has been shown to affect alternative splicing in a way that depends on its binding to 
specifically methylated histones via a linker protein (Luco et al., 2010). Conversely, inhibition 
of splicing has been shown to disrupt normal patterns of H3K36 methylation (Kim et al., 
2011). While it is not clear what initiates the pattern of histone methylations and how these are 
used to guide splicing, a tempting hypothesis is that splicing guides the establishment and/or 
maintenance of the pattern, which in turn affects splicing by recruiting splicing factors and/or 
by affecting transcription kinetics during the following rounds of transcription (Kim et al., 
2011). 
1.6.5 Alternative splicing of U12-type introns 
Alternative U12-type splicing events are rare, possibly due to the more rigid sequence 
constraints on the U12-type 5'ss and BPS and their co-operative recognition. Also, exon 
skipping (Figure 6C), which is the most common form of alternative splicing in mammals, is 
not observed due to the fact that U12-type introns rarely occur more than once in a gene and 
U2-type and U12-type splice sites are incompatible with each other. The distance constraints 
between a U12-type BPS and 3'ss also limit splicing at alternative 3'ss AG dinucleotides, 
although theoretically use of closely spaced sites would be possible. Such splicing events have 
been observed, but whether they are true regulated alternative splicing events or noise in the 
splicing process is not clear (Levine and Durbin, 2001; Zhu and Brendel, 2003; Chang et al., 
2007a). In some cases, retention of U12-type introns affects a significant portion of transcripts 
(Pessa et al., 2006). In general, transcripts containing U12-type introns are more likely to give 
rise to alternative isoforms through retention of the U12-type intron than through alternative 
U12-type splice site usage, but the biological significance of these isoforms is also unclear. 
Alternative usage of mutually exclusive U12-type and U2-type splice sites has been observed 
in at least two cases. The Drosophila melanogaster gene prospero contains a "twintron", a 
U12-type intron which in itself contains a U2-type intron (Hall and Padgett, 1994). The 
decision to splice by either the U12 or the U2-dependent pathway is affected by an intronic 
element which binds the D. melanogaster homologues of hnRNPA1 (Scamborova et al., 2004; 
Borah et al., 2009). In vertebrates, the members of the JNK gene family contain a hybrid 
intron with a U12-type 5'ss and U2-type BPS and 3'ss. These can be spliced in a mutually 
exclusive fashion to either the 5'ss of the upstream U2-type intron or to the 3'ss of the 
downstream U12-type intron (Chang et al., 2007a), and at least in mice these isoforms show 
tissue-specificity, with the latter isoform preferentially expressed in neurons (Casanova et al., 
1996). 
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1.7 Quality control and nonsense-mediated decay 
1.7.1 Nuclear degradation of aberrant transcripts 
Despite the multiple mechanisms that ensure fidelity in splicing, low levels of mis-splicing are 
quite common (Melamud and Moult, 2009), producing "noise" transcripts, which might 
potentially code for deleterious protein isoforms (Faustino and Cooper, 2003). Cells contain a 
number of mechanisms to avoid and remove such aberrant transcripts. One way is to increase 
the fidelity of splicing. Indeed, long transcripts that contain many introns, and are therefore 
more vulnerable to splicing mistakes, contain more ESEs (Melamud and Moult, 2009). 
Transcripts that do not fully undergo splicing are generally retained in the nucleus and 
degraded by the exonuclease Rat1p/Xrn2, or by the nuclear exosome, which has both exo- and 
endonuclease activity, and associates with the elongating RNAPII (reviewed by Egecioglu and 
Chanfreau, 2011). The mechanism by which unspliced transcripts become specifically 
retained in the nucleus remains unclear. One possibility is that general retention factors may 
prevent the export of all transcripts, and those which are not processed fast enough become 
degraded, while efficiently processed transcripts gain markers that qualify them for export, 
including a poly-A tail and specific protein complexes. 
1.7.2 Splicing is linked to mRNP export 
One of the markers linking splicing to export are exon-junction complexes (EJCs), which are 
protein complexes deposited 20–24 nt upstream of the exon ligation sites, and whose 
recruitment is likely initiated by interactions with spliceosome components (reviewed by Bono 
and Gehring, 2011). The EJC core serves as a platform for various protein factors involved in 
splicing, mRNP export and mRNP quality control. The transcription-export complex (TREX) 
contacts the EJC, as well as 5' cap-binding proteins, components of the 3' end-processing 
machinery and the spliceosome (reviewed by Björk et al., 2009). Among the proteins bound 
by TREX is the export receptor Nxf1, which also directly interacts with hypophosphorylated 
SR proteins, suggesting that the recruitment of export factors is linked to the spliceosomal 
rearrangements leading to splicing catalysis (reviewed by Björk et al., 2009; Zhong et al., 
2009; see also chapter 1.6.4.1). Consistently, spliced RNA is exported more efficiently than 
identical RNA expressed from complementary DNA (Valencia et al., 2008). 
After their release from the transcription site, the mRNPs move through the nucleus 
apparently by diffusion, possibly directed by channels formed between volumes of chromatin 
(reviewed by Björk et al., 2009). Upon reaching the nuclear pore complex, the mRNP 
structure and composition changes, and some of the associated protein factors are released. 
However, some of the protein complexes, including the EJCs, remain attached to the mRNP in 
the cytoplasm, where they play important roles in enhancing and regulating translation and in 
further quality control, such as in the nonsense-mediated decay (NMD) pathway. 
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1.7.3 Nonsense-mediated decay 
Despite nuclear quality control mechanisms, some aberrantly processed mRNAs are 
transported into the cytoplasm, and further cytoplasmic control mechanisms are therefore 
needed. NMD is the most well-known of these mechanisms (reviewed by Chang et al., 
2007b). Although NMD can be activated by several mechanisms, the most common one is 
through EJCs and premature termination codons (PTCs). During the initial round of 
translation, the ribosome releases EJCs from the mRNP. As the ribosome reaches the STOP 
codon, the release factors eRF1 and eRF2 likely recruit the NMD factor Upf1. Although the 
specific details of NMD activation are not known, it is likely that NMD is initiated if Upf1 can 
interact with Upf2 and Upf3, which are components of the EJC. Such an interaction can only 
take place with an EJC that has not been displaced from the transcript and must therefore be 
downstream of the STOP codon, signaling that the STOP codon is upstream of a splicing 
event and therefore premature. Additionally, the EJC has to be sufficiently far downstream, ca. 
50 nt, probably to allow for sufficient space for both the translation termination complex and 
the EJC. Activation of NMD is counteracted by the poly-A-binding protein, PABP, when 
located close to the STOP codon, thus ensuring that correctly processed mRNAs escape NMD 
(Eberle et al., 2008; Singh et al., 2008). Once activated, NMD leads to decapping of the 
transcript and degradation by the cytoplasmic exosome and other nucleases. 
1.8 Conserved sequence elements and regulation of splicing 
factors through nonsense-mediated decay 
1.8.1 Most NMD events are caused by splicing errors 
NMD is not only utilized in the degradation of accidentally mis-spliced transcripts, but can 
also be functionally coupled to alternative splicing (AS-NMD). Alternative splicing can 
introduce PTCs into mRNAs either by inclusion of PTC-containing sequence fragments, or by 
inclusion of other fragments that cause a frameshift in downstream sequences, resulting in the 
formation of a PTC. Some of these events can be used to regulate final mRNA levels. Initial 
computational approaches predicted 35% of observed mRNA isoforms in the Refseq database 
to be subject to NMD (Green et al., 2003; Lewis et al., 2003). However, it was later 
discovered experimentally that the number of events subject to NMD was much lower, and 
that only a fraction of all AS-NMD events show any signs of being regulated and are greatly 
outnumbered by stochastic noise caused by the splicing machinery (Mendell et al., 2004; Pan 
et al., 2006; Wittmann et al., 2006). 
1.8.2 Conserved NMD-inducing elements in splicing factor genes 
An evolutionary approach searching for conservation of AS-NMD events led to the discovery 
of a group of proteins that are commonly regulated through AS-NMD, namely those involved 
in RNA processing, and particularly in splicing (reviewed by McGlincy and Smith, 2008). The 
PTC-introducing alternative splicing events occur within conserved regions that are 100–200 
nt long, and take place in transcripts coding for core spliceosomal proteins, SR proteins, 
hnRNPs, and other splicing factors, such as Nova and Fox proteins (Lareau et al., 2007; Ni et 
al., 2007; Yeo et al., 2007; Saltzman et al., 2008). One of the striking discoveries was that all 
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human SR proteins are regulated through AS-NMD, and the pattern of alternative splicing is 
also conserved in mouse (Lareau et al., 2007). Similar AS-NMD events are also found in the 
SR protein transcripts in other animals and in fungi, but the location and even the number of 
PTC-inducing alternative splicing events varies, and transitions from one AS-NMD event to 
another are apparent between certain species (L. Lareau, personal communication). Thus, it 
appears that it is not the precise position of the alternative splicing event that is conserved 
during evolution, but the mode of AS-NMD regulation as a whole. It is therefore likely that 
AS-NMD is an ancient and wide-spread mechanism for regulating splicing factors. As a 
process that is directed by splicing-dependent EJCs, AS-NMD is indeed well suited to 
function in regulation of splicing factors. The fact that no changes are generally required in the 
protein coding region of the genes, especially when nonsense exons are involved, also helps to 
explain the apparent high preference for preserving AS-NMD regulation in these genes, as 
well as how it has apparently arisen independently several times during evolution. 
1.8.3 Feedback regulation of splicing factors 
Although the precise mechanism regulating the activation of AS-NMD is not known in all 
cases, certain common features suggest that feedback regulation by the products of the same 
gene is often involved (Ni et al., 2007): In SR protein transcripts, PTCs are commonly 
introduced by inclusion of alternative nonsense exon, suggesting SR proteins activate their 
inclusion through ESEs. Conversely, in hnRNP transcripts (including hnRNPs H1, K and M 
and nPTB) PTCs occur due to frameshifts caused by exon skipping, suggesting splicing 
repression through ESSs. A computational search also identified a number of splicing factor 
genes with conserved elements, in which the NMD-inducing alternative splice sites were 
surrounded by known binding sites for the product of the same gene (Yeo et al., 2007). Taken 
together, these results suggest that AS-NMD may be utilized for widespread homeostatic 
regulation of splicing factors, which are possibly regulated in a co-ordinated fashion (Ni et al., 
2007). 
The feedback regulation of several SR proteins and hnRNPs has been studied in detail. The 
SR proteins SRSF2 (also known as SC35) and SRSF7 (9G8) activate alternative splice sites in 
their respective pre-mRNAs, resulting in the inclusion of PTCs (Lejeune et al., 2001; Sureau 
et al., 2001). In many cases, the feedback regulation of splicing factors is also linked to 
crossregulation of closely related factors. SRSF1 (ASF/SF2) and SRSF3 (Prp20) both promote 
inclusion of PTCs in their own transcripts, while SRSF1 inhibits the PTC-inducing splicing 
event in the SRSF3 transcript (Jumaa and Nielsen, 1997; Sun et al., 2010). The core 
spliceosomal factor SmB/B' regulates its own expression through AS-NMD, but this 
alternative splicing event can apparently also be affected by the levels of its homolog SmN 
(Saltzman et al., 2008; Saltzman et al., 2011). The alternative splicing isoforms of hnRNPA1 
are regulated by itself and hnRNPA2 (Chabot et al., 1997; Hutchison et al., 2002), and the 
hnRNPA2B1 transcript, the splicing isoforms of which code for hnRNPs A2 and B1, is also 
subject to autoregulation through AS-NMD (McGlincy et al., 2010). HnRNPL regulates its 
own expression as well as that of the related hnRNPLL protein (Rossbach et al., 2009). A very 
interesting cycle of tissue-specific crossregulation involves PTB and its paralogs, the neuron-
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specific nPTB, and ROD1, which is mainly expressed in haematopoietic cells. PTB and nPTB 
both regulate their own levels through AS-NMD, and PTB activates AS-NMD of the nPTB 
transript in non-neuronal cells (Wollerton et al., 2004; Spellman et al., 2007). PTB and nPTB 
also activate formation of a PTC in the ROD1 transcript through exon skipping, although this 
does not necessarily lead to NMD (Spellman et al., 2007). 
Like many other aspects of splicing, the mechanisms of feedback regulation are also linked to 
other processes of the gene expression pathway. For example, the U1 snRNP component U1A 
is downregulated by inhibition of polyadenylation caused by binding of two U1A molecules 
and U1 snRNP at the 3' untranslated region (UTR) of the transcript (Boelens et al., 1993; 
Guan et al., 2007). Same factors can also be regulated on multiple post-transcriptional levels:  
SRSF1 promotes the splicing of various different SRSF1 isoforms, some of which code for 
proteins or are degraded by NMD, while others suppress gene expression on a translational 
level independently of NMD (Sun et al., 2010). Conversely, some ribosomal proteins are 
regulated through AS-NMD, which they can even promote themselves (Cuccurese et al., 
2005; Russo et al., 2011), thus highlighting the multiple roles of RNA-binding proteins.  
The reason for the association of AS-NMD with highly conserved sequences remains an 
unresolved issue. In general, introns flanking alternative exons show more conservation than 
constitutive exons, but splicing regulation is also typically quite redundant, and most highly 
regulated splicing events do not require such a high degree of conservation (reviewed by 
McGlincy and Smith, 2008). The reason may in part lie in the fact that many of these AS-
NMD events are likely to function in the homeostasis in splicing factors. It has been observed 
that transcriptional feedback loops with strongly repressive regulation tend to result in 
oscillatory effects on gene expression, while lowly repressive regulation results in more 
constant expression (McGlincy and Smith, 2008). It is possible that the homeostasis of 
splicing factors similarly requires a particularly controlled level of AS-NMD-induced 
repression, and, consequently, a large number of various factors fine-tuning that repression. 
These in turn may require extensive sequence elements as their platforms, as well as highly 
defined sequences within these platforms in order to maintain the (possibly overlapping) 
binding sites for all factors. 
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2 Aims of the study 
This study was initiated in order to characterize in more detail factors involved in the 
recognition of U12-type introns. Unlike the 5'ss nucleotides of U2-type introns, the first three, 
highly conserved nucleotides (RUA) of U12-type introns do not base-pair to snRNAs, 
suggesting that unidentified protein components are responsible for recognizing this motif. 
This indicated mechanistic differences in intron recognition between the two spliceosomes. 
These differences were likely to be linked to the regulation of the U12-dependent 
spliceosome, and as such of great interest to deciphering its role in controlling the expression 
of genes with U12-type introns. In order to shed light on these matters, I aimed at finding and 
characterizing the protein component or components specifically interacting with this motif, 
and defining how they are regulated or could regulate the U12-dependent spliceosome. After 
the discovery of the U11-48K protein as the 5'ss-recognizing factor, it became obvious that the 
aberrantly spliced isoforms of its pre-mRNA, as well as those of the U11/U12-65K protein, 
could be diagnostic of feedback regulation of U11/U12 di-snRNP levels through a conserved 
sequence element present in both pre-mRNAs. The latter part of my project was therefore 
aimed at verifying the interaction of U11/U12 di-snRNP with the 5'ss-like motifs within this 
elements, as well as finding other splicing regulatory elements within the conserved sequence, 
and characterizing the effects of trans-acting factors binding to them. 
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3 Materials and methods 
 
Methods used in this study are listed in Table 1. For detailed description of the methods, see 
the original publications. 
 
Table 1. Methods used in this study. 
Method Article 
Cell fractionation I, II 
Cell lines and culture I, II, III 
Far-Western overlays II 
Glycerol gradient centrifugation I 
Immunoprecipitation I, II, III 
In vitro splicing and spliceosome assembly assays I, II 
In vivo splicing block using oligonucleotides II 
Luciferase expression assays II 
NMD inhibition II 
Northern blotting I, II, III 
Protein-RNA crosslinking I, III 
Quantitative RT-PCR I, II 
Reporter plasmids II, III 
RNAi knockdown I, II 
RNA-RNA crosslinking II, III 
RNase H protection assays I 
RT-PCR I, II, III 
Sequence alignments I, II, III 
StrepII tag pulldown assays I 
Streptavidin pulldown assays I, II 
Translation inhibition II 
Western blotting II 
Yeast two-hybrid assays I 
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4 Results and discussion 
4.1 U11-48K protein recognizes the U12-type 5' splice site and is 
essential for U12-dependent splicing (I) 
4.1.1 U11-48K specifically recognizes the U12-type 5' splice site during 
initial intron recognition 
The main difference in the assembly of the two spliceosomes seems to be the initial intron 
recognition phase, which takes place in multiple steps in the major spliceosome, while minor 
introns are recognized by the preformed U11/U12 di-snRNP (chapter 1.5.5; Figure 4). The 
initial base-pairing interactions at the 5'ss are also different in the two spliceosomes. The 
consensus 5'ss sequence of major introns is complementary to U1 snRNA from position -2 to 
+6. In contrast, the first three nucleotides (RUA) of minor introns are not recognized by U11 
snRNA (see Figure 1 in I). However, the almost universal conservation of the RUA motif 
(Sheth et al., 2006), as well as the fact that the first two nucleotides are critical for splicing 
(Dietrich et al., 2005), suggested that the motif is recognized through sequence-specific 
interactions with some other splicing factor. As the functions of most of the proteins specific 
to the U11/U12 di-snRNP (Will et al., 2004) remained unknown, it appeared likely that one or 
several of them might be involved in 5'ss recognition. 
To test this hypothesis, I performed in vitro splicing assays in HeLa nuclear extracts with the 
widely used P120 splicing substrate containing a U12-type intron with AU-AC termini.  As 
there was no prior experimental evidence for the significance of the third nucleotide of the 
U12-type 5'ss sequence (A+3), I initially tested spliceosome assembly and splicing catalysis of 
substrates mutated at the +3 position. I found that at least in the context of the in vitro assays, 
A+3 is essential for both spliceosome assembly and catalysis. An A+3G mutant was then used 
as a negative control in RNA-protein crosslinking assays. To detect proteins specifically 
binding to the 5' end of the intron, I placed a single photoactivatable 4-thio-uridyl residue 
followed by a radioactive phosphate group at the +2 position of the P120 splicing substrate. 
Using the A+3G mutation and a mutation blocking U11 snRNA binding (CC+5+6GG) as 
negative controls, I discovered that a single protein crosslinks specifically to the wild type +2 
position (see Figure 3 in I for substrate RNAs and crosslinked proteins). By performing 
immunoprecipitation with antibodies specific to the proteins of the U11/U12 di-snRNP, this 
protein was recognized as U11-48K (henceforth referred to as 48K). This interaction was also 
observed with a novel splicing substrate derived from the mouse Vps16 gene, which contains a 
U12-type intron with GU-AG termini, verifying that the 48K interaction is not restricted to the 
AU-AC subtype of U12-type introns. 
To address the generality of 48K functions, 48K was knocked down by RNAi in HeLa cells, 
which resulted in reduction of 48K mRNA levels to ca. 10–15 % of the original level. This led 
to a significant cell growth arrest (70% reduction), comparable to that caused by knockdown 
of another essential splicing factor, Prp8 (90%).  Thus, 48K has an essential function for cell 
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viability. I and my colleagues also observed reduced splicing of a number of U12-dependent 
introns, confirming that 48K has an essential and general function in U12-type intron 
recognition.  In addition to reduced U12-dependent splicing, we observed activation of cryptic 
U2-type splice sites in the vicinity of U12-type splice sites. Importantly, this indicates that the 
splicing defect caused by 48K knockdown affects the intron recognition step, and not a later 
phase in the spliceosome assembly or catalysis, as such introns would already be committed to 
splicing by the U12-type spliceosome. This is also confirmed by my in vitro crosslinking 
analyses: The 48K-5'ss interaction precedes the formation of the stable, ATP-dependent A 
complex (see chapter 1.5.4), as it does not require ATP. It also precedes the formation of 
U12/BPS base-pairs, as it can form in the presence of an oligonucleotide blocking U12/BPS 
basepairing, and even in the absence of a BPS. However, 2–4-fold increase in 48K 
crosslinking was observed with substrates that were able to form U12/BPS basepairs. These 
results are consistent with previous results showing that while U11 basepairing to the 5'ss 
precedes U12/BPS interactions, U11 binding is enhanced by co-operative recognition of the 
BPS (Frilander and Steitz, 1999). 
Such kinetic effects are also likely to be linked to differences in splicing efficiency of different 
U12-type introns, as reduced splicing after 48K knockdown was not observed for all U12-type 
introns. Similarly, depletion of major snRNPs has been observed to affect the splicing of 
specific introns, most likely caused by competition between strong and weak sites (see chapter 
1.6.4.4). Kinetic competition may become particularly significant in the U12-dependent 
spliceosome due to co-operative recognition of the 5'ss and BPS, as under normal 
circumstances binding defects at one site could be compensated by enhanced binding at the 
other site. Indeed, the introns that were most severely affected after 48K knockdown generally 
had poor 5'ss and/or BP sequences (see Figure 5F in I), suggesting that their recognition has 
been compromised due to reduced affinity for the 5'ss. These results also support the notion 
that 48K functions by stabilizing 5'ss/U11 snRNA binding. 
Due to our inability to express recombinant 48K in significant amounts, we were unable to 
study the interactions of 48K and the 5'ss in more detail in vitro and show how 48K stabilizes 
U11 binding, or whether the sequence specificity is conferred by 48K itself or by an additional 
splicing factor not detected by the crosslinking assay. Also, we were not able to show which 
domain of 48K is responsible for 5'ss recognition, although we did detect an evolutionarily 
conserved novel CHHC zinc finger (ZnF) motif in the N-terminal part of 48K, which we 
suggested as a possible RNA or protein recognition motif (see Supplementary Figure S1 in I). 
Fortunately, these questions were later addressed by nuclear magnetic resonance (NMR) 
studies of Tidow and co-workers. They showed that the 48K ZnF domain adopts a novel fold 
found in a few other RNA binding proteins (Andreeva and Tidow, 2008), and that this domain 
binds to short RNA oligonucleotides with a U12-type 5'ss sequence both in the presence and 
absence of an oligonucleotide mimicking the 5' end of U11 (Tidow et al., 2009). 48K binding 
to the U11/5'ss helix was found to be independent of salt concentration, but binding to 5'ss 
RNA alone occurred only under low salt conditions. Combined with our results, it is thus 
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evident that 48K binds to the U11/5'ss helix during its formation or shortly thereafter, and also 
interacts with the unbase-paired nucleotides of the RUA motif, stabilizing the U11/5'ss helix.  
As no RUA mutants were used in the study by Tidow et al. (2009), it still remains unclear 
whether 48K alone recognizes the RUA motif in a sequence-specific manner. SR proteins 
have been shown to interact directly with the U12-type 5'ss (Shen and Green, 2007), and 
might be involved in guiding or stabilizing the 48K-5'ss interaction. Similarly, other proteins 
in the U11/U12 di-snRNP might affect 5'ss recognition (see chapter 1.5.5). It was previously 
suggested that the U11/U12-20K protein (hereafter 20K) might function in 5'ss recognition 
analogously to the U1C protein. However, we were unable to detect 20K in our crosslinking 
assays (I), and knockdown of 20K had minimal effects on the feedback regulation of 48K and 
65K proteins (Figure 5C in II; see chapter 4.2), suggesting it is not involved in 5'ss 
recognition. While 48K does not share sequence similarity with U1C, there are certain 
similarities between the two proteins that suggest that they may nonetheless function in a 
similar manner in 5'ss recognition in the two spliceosomes, as discussed in more detail in the 
following chapter. 
4.1.2 Parallels between 5' splice site recognition and cross-intron 
interactions in the two spliceosomes 
U1C has been implicated in stabilizing the U1/5'ss helix through a CCHH ZnF domain (Muto 
et al., 2004; Pomeranz Krummel et al., 2009). Our results, as well as those of Tidow et al. 
(2009) support a similar role for 48K. Somewhat controversially, it has been suggested that 
U1C can also recognize the 5'ss in the absence of U1/5'ss base-pairing both in humans and in 
baker's yeast (Rossi et al., 1996; Du and Rosbash, 2002). These results need not be 
contradictory, as our results and those of Tidow et al. (2009) suggest that the 48K can also 
interact with ssRNA (the RUA motif) and the U11/5'ss helix. However, despite a similar 
overall fold, the ZnF motifs of 48K and U1C are different. The NMR structure of the free 48K 
ZnF domain has two β-strands followed by an α-helix, (interrupted by one π-turn; Tidow et 
al., 2009). The U1C ZnF is composed of two β-strands followed by three α-helices, A, B and 
C, the latter two of which are reorganized in the crystal structure of U1 snRNP to yield one 
long α-helix B (Muto et al., 2004; Pomeranz Krummel et al., 2009), which is analogous to the 
α-helix in the 48K ZnF. In 48K, it is the N-terminal part of the α-helix and the preceding β-
turn that have been implicated in RNA binding based on chemical shifts (Tidow et al., 2009). 
In the structure of the U1 snRNP, the 5' ends of two U1 snRNAs base-pair to one another in a 
way that has been suggested to be similar to U1/5'ss base-pairing, and in this structure U1C 
contacts the RNA helix using the α-helix and β-turn analogous to those of 48K. Interestingly, 
the short helix A of U1C ZnF, which has no counterpart in 48K, seems to bind the minor 
groove of the RNA helix at the site corresponding to the first two nucleotides of the intron 
(Pomeranz Krummel et al., 2009), which do not participate in base-pairing in the minor 
spliceosome. Thus, despite their dissimilar sequences, 48K and U1C may have evolved similar 
ZnF domains in parallel, and may use similar strategies in recognizing their targets, but are 
specifically equipped to deal with the differences in their RNA environment. It is important to 
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notice, however, that no structure of the 48K ZnF domain in complex with RNA has been 
published, and this might prove to be quite different from that of the solution structure or the 
U1C-RNA complex. 
To study how 48K associates with the U11/U12 di-snRNP, we performed yeast two-hybrid 
assays with 48K and other U11/U12 proteins. The only observed interaction was with U11-
59K protein (henceforth 59K). This result was further verified by far-Western overlays and 
pulldown assays, which also helped in localizing the interacting domains to the central part of 
59K and the N-terminal domain of 48K. This N-terminal (amino acids 1–92) part of 48K also 
contains the ZnF domain interacting with the 5'ss. Interestingly, N-terminal fragment 
containing the ZnF domain of U1C (aa 1–45), can also associate with the U1 snRNP on its 
own (Nelissen et al., 1991; Muto et al., 2004). It is possible that this proximity of the 5'ss-
binding and protein interaction interfaces serves a purpose in bringing the 5'ss close to other 
functional parts in the spliceosome. Indeed, both U12 and U2 are close to the 5'ss during the 
earliest phases of intron recognition in their respective prespliceosomes (Frilander and Meng, 
2005; Dönmez et al., 2007). In the major spliceosome, the 5'ss and BPS are brought together 
by non-snRNP proteins interacting with U1 and U2 (see chapter 1.5.5). Our observation of 
48K interaction with 59K provides insights into how the 5'ss and BPS are bridged in the minor 
prespliceosome by internal components of the U11/U12 di-snRNP. Previous studies have 
indicated that 59K resides at the interface of U11 and U12 snRNPs and interacts with the 
U11/U12-65K protein, which directly binds to the 3' end of U12 snRNA (Benecke et al., 
2005). Thus, 48K is part of a molecular chain that links the two catalytically functional intron 
sites during prespliceosome assembly (see Figure 8 in I for a model). 
4.1.3 U11-48K contributes to U11/U12 di-snRNP formation or stability 
In order to see how these protein-protein interactions of 48K affect the U11/U12 di-snRNP 
structure, the fraction of intact di-snRNPs in nuclear extracts from 48K knockdown cells was 
assayed by glycerol gradient fractionation and by co-immunoprecipitation with an antibody 
specific to the U12-associated SF3b155 protein. The results indicated a ca. 50% decrease in 
the level of mature 18S U11/U12 di-snRNPs in the knockdown extracts vs. control extracts. 
This suggests that 48K does contribute to either the formation or stability of the di-snRNP. 
This reduction also likely contributes to the decrease observed in U12-dependent splicing 
observed in the knockdown cells. Due to the low levels of U12-type factors in the cells, and 
the relatively weak antibodies at our disposal, we were not able to ascertain whether the 50% 
reduction in di-snRNP levels directly reflects 48K protein levels, or whether 48K levels are 
even lower. However, it is unlikely that a 50% reduction in di-snRNP levels alone would 
cause the observed effects, as snRNPs are present in a large excess in the cell, and even 
residual levels (< 20%) of the most scarce U12-type snRNA, U4atac, are enough to support 
splicing at wild type levels (Pessa et al., 2006). Therefore, 48K protein levels are likely to be 
reduced by more than 50%, as suggested by the reduction in the mRNA levels, and the 
absence of 48K likely affects the splicing of U12-type intron mainly by directly hindering 
proper 5'ss recognition. 
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4.2 The level of U11/U12 di-snRNPs is regulated through a 
conserved feedback mechanism (II) 
4.2.1 Highly conserved sequence elements in the genes encoding U11-
48K and U11/U12-65K  
The discovery of 48K as a key factor in 5'ss recognition sparked an interest in its regulation, as 
regulating its function could directly affect the activity of the U12-dependent spliceosome. An 
investigation into the transcripts expressed from the gene encoding 48K, SNRNP48, revealed 
that it is spliced at alternative sites which are expected to give rise to PTCs, and these events 
take place in highly conserved intronic sequence elements (see Figure 1 in II), similar to the 
AS-NMD-mediated feedback regulation of SR proteins and hnRNPs (see chapter 1.8.2). The 
expressed mRNAs contain two PTC-containing isoforms. In one of them, an alternative U2-
type 3'ss is activated in intron 4, leading to inclusion of a PTC residing in the intronic region 
between that 3'ss and exon 5. The second isoform is spliced at the same 3'ss, but also at a 5'ss 
only 8 nt downstream, causing inclusion of a small exon (exon 4i), resulting in a frameshift 
and PTC inclusion in exon 5. Most intriguingly, these alternative U2-type splice sites are 
situated upstream of an element containing a tandem repeat of two perfect U12-type 5'ss 
motifs. The U12-type sites were not found to be active splice sites in any of the expressed 
mRNAs, suggesting they perform a regulatory function. Thus, it appeared likely that the 5'ss-
like motifs could act as sensors for functional U11 snRNP or U11/U12 di-snRNP levels, such 
that their binding could activate splicing at the upstream U2-type splice sites through exon 
definition interactions, eventually resulting in destruction of the transcripts by NMD. Thus, we 
refer to the element formed by the two U12-type 5'ss-like motifs as the U11 snRNP-binding 
splicing enhancer, or USSE. 
The larger, ca. 110 bp element containing the USSE is almost completely conserved in 
mammals, more so than some of the exons in the SNRNP48 gene. In more distantly related 
organisms, such as fish and insect species, the conservation is mainly limited to the USSE 
itself and the upstream U2-type splice sites, especially the 3'ss, suggesting that these 
sequences comprise the core elements of the feedback regulation. Strikingly, the USSE is also 
found in the plant genes coding for 48K. However, in plants it is located in the 3' UTR of the 
genes, and is associated with an upstream U2-type 3'ss. Our RT-PCR result show that in 
Populus trichocarpa and Arabidopsis thaliana the transcripts are indeed spliced alternatively 
at the 3'ss upstream of the USSE to produce mRNAs with 3' UTRs of differing length. The 
apparent similarity in the structures of the USSE and the associated elements suggest that this 
mode of regulation has had a significant function already in the common ancestor of plants 
and animals. Furthermore, the differences in the location of the element suggest that it is the 
mechanism of feedback regulation that is conserved, not the site of regulation, as also 
suggested for AS-NMD-mediated regulation of SR proteins (see chapter 1.8.2). 
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A bioinformatic search for conserved USSE elements in other genes revealed a similar 
element only in one gene, RNPC3, which codes for another U11/U12-specific protein, 65K. 
The 65K USSE is located in the 3' UTR, similar to the plant 48K, and alternative U2-type 
activation upstream of the USSE also leads to expression of transcripts with longer 3' UTRs. 
The 65K USSE is well conserved in vertebrates, but we failed to find it in other eukaryotes, 
suggesting the 65K feedback regulation may have arisen independently in the ancestor of 
vertebrates, possibly by transfer of the USSE element from the SNRNP48 gene. As 48K and 
65K are both components of the U11/U12 di-snRNP, this may have improved the regulation 
of the activity of the U12-dependent spliceosome. 
4.2.2 The USSE directs alternative splicing and mRNA destabilization 
To verify the function of the USSE in the regulation of 48K and 65K, human embryonic 
kidney cells (HEK293) were treated with oligonucleotides blocking the binding of U11/U12 
di-snRNPs to the USSE. As expected, blocking the USSE resulted in decreased inclusion of 
the nonsense exon or in the absence of the long 3' UTR isoform in the endogenous mRNAs 
coding for 48K or 65K, respectively. The same results were obtained with reporter plasmids 
containing mutations in one or both of the 5'ss-like motifs in the USSE, suggesting both of the 
motifs are required for splicing enhancement by USSE. Most importantly, the effect of USSE 
mutations was rescued by expression of a U11 snRNA with compensatory mutations, 
indicating that U11 snRNA base-pairing to the USSE is essential for its activity.  
The inclusion of PTCs suggests that 48K is regulated through AS-NMD, similar to SR 
proteins. This hypothesis was tested by inhibition of translation by cycloheximide, and by 
inhibiting NMD by expressing a dominant negative form of Upf1. Both approaches resulted in 
stabilization of nonsense exon-containing isoforms of 48K mRNA, indicating that alternative 
splicing activated by the USSE results in destruction of the mRNA by NMD. In contrast, 65K 
transcripts were unaffected by inhibition of NMD. It was found that the 65K transcripts with 
long 3' UTRs were specifically destabilized in the cytoplasm, suggesting that a cytoplasmic 
process other than NMD degrades the 65K transcripts. 
Knockdown of 48K also resulted in a significant increase in the levels of 65K mRNA, 
indicating that it is actively down-regulated by the USSE. Similarly, knockdown of 35K led to 
increase in both 48K and 65K mRNA levels. Interestingly, 35K interacts with SR proteins, 
similar to U1-70K (see chapter 1.5.5), which functions in exon-definition interactions in the 
major spliceosome. It is therefore possible that 35K mediates the activation of the upstream 
splice sites, potentially through SR proteins. It is also notable that while previous results have 
shown enhanced U12-dependent splicing through exon-definition interactions with U2-type 
factors (see chapter 1.6.2), our results show for the first time that components of the U12-
dependent spliceosome can also activate U2-dependent splicing. 
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4.3 Activation of AS-NMD in the U11-48K transcript is regulated 
by multiple factors (II, III) 
4.3.1 The USSE binds U11/U12 di-snRNPs (II) 
To study the splicing activation by the USSE, I chose to characterize the components 
interacting with the 48K USSE in more detail in vitro. Native gel analyses indicated that two 
spliceosome-like complexes assembled in HeLa nuclear extracts on short RNAs containing the 
USSE. I then performed pulldown experiments with short biotinylated RNAs to identify 
snRNAs binding to the USSE, as well as psoralen crosslinking experiments to detect RNA-
RNA interactions. U11 snRNA binding to the USSE was observed with both methods. U12 
snRNAs were also found to be present in the USSE-binding complex, but no RNA-RNA 
interactions were detected. U11 crosslinking and U11 and U12 binding was completely lost 
with substrates containing A+3G or CC+5+6GG mutations in both 5'ss-like motifs, indicating 
that recognition by both U11 snRNA and 48K is required, similar to recognition of a bona fide 
U12-type 5'ss. Intermediate levels of U11 and U12 snRNA binding in pulldown experiments 
was observed with substrates mutated only at one 5'ss-like motif. Similarly, U11 crosslinks 
formed to both motifs independently. This suggests that the USSE motifs bind U11/U12 di-
snRNPs independently (at least in vitro), and that both motifs are occupied in wild type 
substrates. This is consistent with the results indicating that both motifs are required for 
splicing enhancement by USSE in vivo. Simultaneous binding may stabilize the complex, or 
the two di-snRNPs may form a platform that is required for interactions with factors mediating 
the activation of upstream U2-type splice sites.  
However, it is not clear whether the activation requires complete U11/U12 di-snRNPs, or 
whether U11 snRNP alone is sufficient, similar to U11 function in regulating the splicing of 
the RSV gag transcript (McNally et al., 2004). My pulldown experiments suggest that each 
RNA substrate binds similar amounts of U11 and U12 snRNAs, suggesting the USSE is 
recognized by U11/U12 di-snRNPs, although the results lack statistical significance. U12 does 
not appear to participate in RNA binding in the USSE: No U12 crosslinks were formed, and 
RNase H-mediated digestion of U12 snRNA had no effect on U11 binding.  However, the 
fragments of digested U12 were pulled down with the complex, indicating that the U12 moiety 
of the di-snRNP did not disintegrate (data not shown). Thus, it may be that the U12 snRNA is 
not necessary for USSE recognition, but it or the protein factors associated with it may be 
required for interactions with other factors. As both the 48K and 65K are targets of the 
feedback regulation, it is likely that 65K, and thus the U12 snRNP, is required for the 
activation of the USSE. Indeed, knocking down 65K by RNAi has proven to be particularly 
difficult (II; Benecke et al., 2005), likely due to the feedback regulation through the USSE, 
suggesting that the process requires 65K. 
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4.3.2 AS-NMD is suppressed by hnRNPF/H and U1 snRNP (II, III) 
The USSE itself constitutes only a small part of the conserved sequence element, and other 
conserved features also likely affect the feedback regulation. One of the observations arising 
from our in vivo studies is that exon 4i is included very weakly in the absence of the USSE, 
despite the strong splice sites surrounding it, suggesting the presence of inhibitory elements. A 
notable feature in exon 4i is a run of four guanosines, which is among the most conserved 
elements in mammalian as well as fish species (see Figure 1 in III). The sequence and location 
of this element suggested that it might function as an ESS by binding hnRNPF/H proteins.  To 
test this hypothesis, I performed protein-RNA crosslinking experiments with longer RNA 
substrates, containing the USSE as well as exon 4i and part of the preceding intron. By 
immunoprecipitation, I identified a strong crosslink to hnRNPH1, as well as a weaker one to 
hnRNPF, both of which occured with wild type substrates but not with substrates with G-run 
mutations. A relatively strong crosslink also formed to a 35 kDa protein, possibly hnRNPH3, 
suggesting that several hnRNPF/H proteins may recognize the G-run in exon 4i. However, I 
was unable to identify this protein by immunoprecipitation. Crosslinks to hnRNPA1 and 
phospho-SR proteins were also detected, but these were not specific to the wild type sequence.  
Binding of U1 to the exon 4i 5'ss was verified by pulldown experiments and psoralen 
crosslinking using the same substrates (see Figures 2 and 3 in II, and Figure 2 in III). Due to 
the proximity of the 5'ss and the G-run, it seemed likely that U1 and hnRNPH1 (or F) could be 
competing for binding. Competition has previously been observed for similarly overlapping 
sites (Buratti et al., 2004), and ESS-bound hnRNPH1 has been shown to be a potent 
suppressor of strong 5' splice sites (Xiao et al., 2009), such as that of exon 4i. To test this, U1 
binding was inhibited with a 2'-O-methyl oligonucleotide, with an increase in hnRNPH1 
crosslinking by ca. 50%, suggesting that U1 and hnRNPH1 are competing for binding. 
However, other protein crosslinks were also intensified upon U1 blockage, and the reciprocal 
experiment of mutating the G-run had no significant effect on U1/5'ss crosslinks. 
To better define the effect of hnRNPF/H on exon 4i inclusion and U1 binding, I transfected 
HEK293 cells with reporter plasmids containing various mutations in the G-run and the exon 
4i 5'ss, as well as in the USSE. The 5'ss mutants cannot be spliced at the 5'ss, but they are still 
spliced at the exon 4i 3'ss, resulting in the inclusion of the downstream intron, similar to the 
longer endogenous NMD-inducing mRNA. Thus, for the purposes of this study, exon 4i 
inclusion was defined as any event resulting in inclusion of the exon, regardless of whether the 
downstream intron was included or not. The results indicate that the G-run does indeed 
function as an ESS, and that U1 inhibits hnRNPF/H binding. However, the results are not 
consistent with a simple model, in which hnRNPF/H represses and U1 activates exon 
inclusion. Instead, splicing at the exon 4i 3'ss occurs most efficiently when both the G-run and 
5'ss are mutated, suggesting that both hnRNPF/H and U1 suppress the 3'ss. However, 
hnRNPF/H appears to be a more dominant repressor, as in the absence of U1 and USSE it can 
completely block splicing to exon 4i, while transcripts with mutations in the hnRNPF/H 
binding site and USSE still allow exon 4i inclusion at low levels.  
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It may appear contradictory that the U1 snRNP bound at the exon 4i 5'ss can function in 
repressing the 3'ss, while also activating the 5'ss itself, at least for a subset of transcripts. It is 
likely that these two functions take place at different stages: The 5'ss of exon 4i is too close to 
the 3'ss to allow U1 to engage in exon definition interactions, as previously observed for other 
short exons (Sterner and Berget, 1993; Hwang and Cohen, 1997; Lewandowska et al., 2005), 
and U1 binding at the 5'ss could inhibit 3'ss recognition sterically. If the 3'ss is activated by the 
USSE, however, U1 snRNP can then function in defining the 5'ss of the downstream intron. 
Therefore, our results suggest that the main target of splicing activation by USSE is the 3'ss. 
Such a strict preferential order for upstream vs. downstream intron removal was also observed 
for an alternative exon in the ATM transcript (Lewandowska et al., 2005). The primacy of the 
3'ss for the feedback regulation is also supported by the fact that the 5'ss activation is not 
necessary for PTC inclusion in the naturally occurring isoforms. 
Although my in vivo results clearly demonstrate the USSE-dependent activation of the 3'ss, I 
failed to detect recruitment of 3'ss-recognizing factors in my in vitro assays. No U2/BPS 
crosslinks were observed, and only a minimal increase in U2 binding was observed with the 
long vs. short substrates in the biotin pulldown assays (II). The precise location of the BPS in 
the intron upstream of exon 4i has not been mapped, and there are several putative U2-type 
BPSs, all of which are highly degenerate. Thus, the proper recognition of the BPS may require 
additional enhancing elements not present in our in vitro RNA substrate. 
The conservation of the 110 bp element also suggests that there are a number of other 
elements and factors that may regulate the activity of the USSE and exon 4i inclusion, and a 
number of putative regulatory elements were discovered computationally (see Supplemental 
Figure S3 in II). The presence of enhancer elements is also suggested by the activation of 
cryptic splice sites in reporters with mutations blocking the binding of U1 and U11/U12 di-
snRNPs to the 5'ss or the USSE, respectively. Such enhancers may function to recruit U1 
and/or U11/U12 under normal circumstances, while activating binding of U1 to cryptic sites 
when the natural sites are inactivated. Also, the TAATT sequence preceding the G-run may 
also be important, as highly similar sequences at the 5' end of exons were found to be 
significant for hnRNPH1-mediated exon silencing (LeFave et al., 2011). However, our data 
show that simultaneous mutation of the G-run, 5'ss and the USSE results in inclusion levels 
similar to the wild type reporter, indicating that the USSE is not strictly required under these 
circumstances. Thus, it appears that the most crucial interactions regulating exon 4i inclusion 
are those between the U11/U12 di-snRNPS bound at the USSE and hnRNPF/H proteins and 
U1 snRNP bound in and adjacent to exon 4i. 
The interplay between inhibitory and activating functions suggests a requirement for finely 
controlled and limited feedback regulation, which has been proposed to be essential for 
maintaining constant protein levels (see chapter 1.8.3). Indeed, the USSE itself also appears to 
be a highly sensitive element for monitoring functional U11 or U11/U12 di-snRNP levels. It 
forms complexes with snRNPs more stably than an isolated 5'ss, but less stably than authentic 
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U12-type introns. Consistent with this, a knockdown of 48K completely inhibits activation of 
the 3'ss upstream of the 65K USSE (see Figure 5D in II), but has only minor effects on the 
splicing of U12-type introns (Figure 5 in I). Additional regulation may be provided by varying 
the levels or activity of hnRNPF/H in different cell lines. It is also possible that the sequences 
surrounding exon 4i form a CERES-like complex splicing regulatory element (see chapter 
1.6.4.5), with multiple factors competing for binding, as suggested by our crosslinking results.  
Further studies are required to decipher the precise nature of these interactions. 
4.4 Evolutionary implications of the USSE 
The presence of a USSE in the genes coding for 48K in animals as well as plants suggests that 
this mode of regulation may have existed in the last common ancestor of eukaryotes (LECA), 
and thus probably represents the oldest known SRE. It also provides further support for a well-
established U12-dependent spliceosome in LECA, as opposed to recent gain in independent 
lineages (see chapters 1.2.2.2 and 1.3.3). Furthermore, it is possible that the activity of the 
USSE is related to the loss of U12-type introns in many lineages. Inactivation of the USSE 
would likely result in disruption of minor spliceosome homeostasis, possibly leading to the 
loss of its rate-limiting function. This in turn would remove the selection pressure against 
mutations that result in conversion of U12-type introns to U2-type introns, ultimately resulting 
in loss of all U12-type introns and the U12-dependent spliceosome. 
Although highly conserved elements regulating AS-NMD in splicing factor genes are common 
(see chapter 1.8), the extreme conservation of the 48K regulatory element in mammals is 
puzzling, considering the fact that in other organisms the conservation is restricted to the 
USSE itself and the upstream 3'ss (see Figure 1 in II). Naturally, the fact that mammals are the 
most extensively studied taxon may cause a bias in our results. Also, mammals are a relatively 
recent taxon, and may not have had as much time to diverge to the same extent as some of the 
other taxa studied here. Interestingly, recent results indicate that, unlike most evolutionary 
lineages studied, the lineage leading from the LECA to mammals shows no signs of extensive 
intron loss (Csuros et al., 2011). It is thus possible that regulation of gene expression through 
splicing has had a more significant role in the past and present members of this particular 
lineage, accounting for the wide-spread use of feedback mechanisms controlling the levels of 





5 Concluding remarks 
The recognition of the U12 and U2-type introns differs with respect to the specific 
components involved and the order in which they interact with the intronic sequences. As the 
later steps of spliceosome assembly are highly similar in both cases, it is likely that the activity 
of a specific spliceosome is regulated through the components involved in intron recognition. 
In this study, I identified the U11-48K protein as an essential splicing factor that specifically 
recognizes U12-type 5' splice sites. The levels of U11-48K, as well as those of U11/U12-65K, 
are regulated through a feedback mechanism involving a highly conserved sequence element, 
USSE, which directs alternative splicing and nonsense-mediated decay. The components 
controlling this event include not only U11/U12 di-snRNPs, but also U1 snRNP and 
hnRNPF/H proteins. These results suggests that the activity of the minor spliceosome is 
controlled by the levels of U11/U12 di-snRNPs, which are fine-tuned by the combined actions 
of multiple splicing factors regulating the expression of U11-48K and U11/U12-65K. 
The conservation of the regulatory mechanism in plants as well as in animals highlights the 
importance and early origin of feedback regulation of splicing factors through alternative 
splicing. Furthermore, the distribution of USSE in various eukaryotes suggests that the USSE 
may be essential for the regulation of the U12-dependent spliceosome and its function as a 
rate-limiting process in gene expression. Thus, the loss of the USSE may predispose the 
organisms in question to increased conversion of U12-type introns into U2-type introns, 
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